Unnamed: 0,title,date,stock,sentiment
94156.0,"Cannabis Stock Gainers And Losers From June 4, 2020",2020-06-04 17:55:00-04:00,ARNA,negative
94157.0,"The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic",2020-06-04 08:13:00-04:00,ARNA,positive
94158.0,Stocks That Hit 52-Week Highs On Wednesday,2020-06-03 10:45:00-04:00,ARNA,neutral
94159.0,"The Daily Biotech Pulse: Regulatory Delay For Novartis' Multiple Sclerosis Drug, FSD Gets Nod For COVID-19 Study",2020-06-03 07:39:00-04:00,ARNA,negative
94160.0,72 Biggest Movers From Yesterday,2020-06-03 05:11:00-04:00,ARNA,neutral
94161.0,"Cannabis Stock Gainers And Losers From June 2, 2020",2020-06-02 16:53:00-04:00,ARNA,negative
94162.0,50 Stocks Moving In Tuesday's Mid-Day Session,2020-06-02 12:21:00-04:00,ARNA,neutral
94163.0,Stocks That Hit 52-Week Highs On Tuesday,2020-06-02 10:33:00-04:00,ARNA,neutral
94164.0,"Cannabis Stock Gainers And Losers From May 29, 2020",2020-05-30 08:59:00-04:00,ARNA,negative
94165.0,48 Stocks Moving In Thursday's Mid-Day Session,2020-05-28 12:28:00-04:00,ARNA,neutral
94166.0,Arena Pharmaceuticals Prices 5.5M Share Common Stock Offering At $50/Share,2020-05-28 08:34:00-04:00,ARNA,positive
94167.0,Hearing Arena Pharmaceuticals Prices 5.5M Share Offering At $50/Share,2020-05-28 08:28:00-04:00,ARNA,positive
94168.0,"The Daily Biotech Pulse: PhaseBio To Start Potential Pivotal COVID-19 Trial, Immunomedics CEO Quits, Tetraphase Receives Sweetened Offer",2020-05-28 08:24:00-04:00,ARNA,neutral
94169.0,28 Stocks Moving in Thursday's Pre-Market Session,2020-05-28 07:34:00-04:00,ARNA,neutral
94170.0,Arena Pharmaceuticals Announces $250M Proposed Public Offering of Common Stock,2020-05-27 16:03:00-04:00,ARNA,neutral
94171.0,"Arena Completes Full Enrollment Of Etrasimod Phase 2 ADVISE Trial For Atopic Dermatitis, Provides Program Updates",2020-05-26 08:38:00-04:00,ARNA,neutral
94172.0,"Jefferies Maintains Buy on Arena Pharmaceuticals, Raises Price Target to $69",2020-05-22 09:21:00-04:00,ARNA,neutral
94173.0,"Cannabis Stock Gainers And Losers From May 21, 2020",2020-05-21 20:47:00-04:00,ARNA,negative
94174.0,Galecto Names Arena Pharma CEO Amit Munshi Its New Chair,2020-05-19 16:11:00-04:00,ARNA,neutral
94175.0,"Cannabis Stock Gainers And Losers From May 18, 2020",2020-05-18 16:47:00-04:00,ARNA,negative
94176.0,"Benzinga's Top Upgrades, Downgrades For May 18, 2020",2020-05-18 09:32:00-04:00,ARNA,positive
94177.0,"Jefferies Initiates Coverage On Arena Pharmaceuticals with Buy Rating, Announces Price Target of $62",2020-05-18 07:11:00-04:00,ARNA,neutral
94178.0,"Cannabis Stock Gainers And Losers From May 14, 2020",2020-05-14 17:15:00-04:00,ARNA,negative
94179.0,"Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C.  and Los Angeles County.",2020-05-13 12:49:00-04:00,ARNA,negative
94180.0,"Cantor Fitzgerald Reiterates Overweight on Arena Pharmaceuticals, Raises Price Target to $68",2020-05-08 06:54:00-04:00,ARNA,negative
94181.0,"Arena Pharmaceuticals Q1 EPS $(2.000) Beats $(2.280) Estimate, Sales $262.000K Miss $1.580M Estimate",2020-05-07 16:28:00-04:00,ARNA,negative
94182.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,ARNA,negative
94183.0,"Cannabis Stock Gainers And Losers From May 4, 2020",2020-05-04 16:44:00-04:00,ARNA,negative
94184.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,ARNA,neutral
94185.0,ESPAÑOL •  Empresas de Cannabis con Acciones el NYSE y NASDAQ: Una Lista Completa,2020-04-14 13:47:00-04:00,ARNA,neutral
94186.0,A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies,2020-04-09 09:50:00-04:00,ARNA,neutral
94187.0,Arena Pharmaceuticals Announces Topline Data For New Development Program,2020-04-01 16:02:00-04:00,ARNA,neutral
94188.0,"Benzinga's Top Upgrades, Downgrades For March 31, 2020",2020-03-31 09:34:00-04:00,ARNA,positive
94189.0,"Guggenheim Securities Initiates Coverage On Arena Pharmaceuticals with Buy Rating, Announces Price Target to $95",2020-03-31 07:13:00-04:00,ARNA,positive
94190.0,"Cannabis Stock Gainers And Losers From March 27, 2020",2020-03-27 18:59:00-04:00,ARNA,negative
94191.0,"Benzinga's Top Upgrades, Downgrades For March 26, 2020",2020-03-26 10:01:00-04:00,ARNA,positive
94192.0,"B of A Securities Upgrades Arena Pharmaceuticals to Buy, Raises Price Target to $56",2020-03-26 06:18:00-04:00,ARNA,positive
94193.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,ARNA,negative
94194.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,ARNA,negative
94195.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,ARNA,negative
94196.0,"Cannabis Stock Gainers And Losers From March 6, 2020",2020-03-06 17:39:00-05:00,ARNA,negative
94197.0,Stocks That Hit 52-Week Lows On Friday,2020-02-28 10:16:00-05:00,ARNA,negative
94198.0,"The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO",2020-02-28 07:28:00-05:00,ARNA,neutral
94199.0,"Cannabis Stock Gainers And Losers From Feb. 27, 2020",2020-02-27 17:10:00-05:00,ARNA,negative
94200.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-27 10:23:00-05:00,ARNA,negative
94201.0,"Cantor Fitzgerald Reiterates Overweight on Arena Pharmaceuticals, Lowers Price Target to $56",2020-02-27 07:06:00-05:00,ARNA,negative
94202.0,"The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates",2020-02-26 09:36:00-05:00,ARNA,negative
94203.0,"Cannabis Stock Gainers And Losers From Feb. 24, 2020",2020-02-25 07:13:00-05:00,ARNA,negative
94204.0,The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace,2020-02-23 18:38:00-05:00,ARNA,neutral
94205.0,"Cannabis Stock Gainers And Losers From Feb. 20, 2020",2020-02-21 09:32:00-05:00,ARNA,negative
94206.0,"The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering",2020-02-14 08:23:00-05:00,ARNA,negative
94207.0,FDA Requests Arena's BELVIQ Be Withdrawn From Market,2020-02-13 15:16:00-05:00,ARNA,neutral
94208.0,Arena Pharmaceuticals shares are trading higher after JP Morgan analysts upgraded the company's stock from Neutral to Overweight.,2020-01-31 11:12:00-05:00,ARNA,positive
94209.0,"JP Morgan Upgrades Arena Pharmaceuticals to Overweight, Announces $58 Price Target",2020-01-31 06:15:00-05:00,ARNA,neutral
94210.0,30 Stocks Moving in Tuesday's Pre-Market Session,2020-01-21 07:30:00-05:00,ARNA,neutral
94211.0,FDA Grants Fast Track Designation To Arena Pharmaceuticals' APD418 For Development In Decompensated Heart Failure Patients,2020-01-16 09:00:00-05:00,ARNA,negative
94212.0,"The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering",2020-01-07 07:57:00-05:00,ARNA,negative
94213.0,"Arena Pharma Offers Strategic Planning Steps For 2020-2021, For Next 5 Years",2020-01-06 16:01:00-05:00,ARNA,neutral
94214.0,Arena Pharmaceuticals And Beacon Discovery Expand Strategic Relationship Focusing On Multiple Immune And Inflammatory Targets,2020-01-02 08:31:00-05:00,ARNA,positive
94215.0,Shares of several healthcare stocks are trading lower as US equities dip following escalating US-China tensions over Hong Kong. US Stocks further fell on worse-than-expected manufacturing data.,2019-12-02 11:31:00-05:00,ARNA,negative
94216.0,"Benzinga's Top Upgrades, Downgrades For November 13, 2019",2019-11-13 09:35:00-05:00,ARNA,positive
94217.0,"Bank of America Initiates Coverage On Arena Pharmaceuticals with Neutral Rating, Announces $51 Price Target",2019-11-13 09:28:00-05:00,ARNA,neutral
94218.0,"JP Morgan Maintains Neutral on Arena Pharmaceuticals, Lowers Price Target to $58",2019-11-08 08:31:00-05:00,ARNA,positive
94219.0,"Arena Pharmaceuticals Q3 EPS $(1.46) Misses $(1.32) Estimate, Sales $1.4M Miss $2.06M Estimate",2019-11-07 16:21:00-05:00,ARNA,negative
94220.0,"The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs",2019-11-07 07:18:00-05:00,ARNA,negative
94221.0,Arena Pharmaceuticals Highlights Presentation Of New Data Regarding Human Mass Balance And Metabolism Profile Of Etrasimod At AAPS,2019-11-06 08:37:00-05:00,ARNA,neutral
94222.0,Arena Pharmaceuticals Announces First Subject Dosed In ADVISE Phase 2 Trial Evaluating Etrasimod In Atopic Dermatitis,2019-10-28 08:35:00-04:00,ARNA,neutral
94223.0,Arena Pharmaceuticals Presented New Data Analyses Demonstrating the Long-Term Safety and Efficacy of Once-Daily Etrasimod in Patients with Moderately to Severely Active Ulcerative Colitis at UEG Week,2019-10-22 16:04:00-04:00,ARNA,positive
94224.0,Arena Pharma Highlights Will Present New Preclinical Atopic Dermatitis Data For Etrasimod At ESDR Meeting,2019-09-17 08:35:00-04:00,ARNA,neutral
94225.0,A Cannabis ETF Looking For Redemption,2019-09-16 08:00:00-04:00,ARNA,neutral
94226.0,26 Stocks Moving in Tuesday's Pre-Market Session,2019-09-03 08:09:00-04:00,ARNA,neutral
94227.0,Shares of several healthcare companies are trading higher as optimism increased for a resolution to the US-China trade war.,2019-08-19 12:31:00-04:00,ARNA,positive
94228.0,"Shares of healthcare companies are trading higher as US markets rebound from recent weakness following a yield curve inversion, which caused recession fears. Trump also recently announced the US would delay China tariffs, renewing hopes of a trade deal.",2019-08-16 13:27:00-04:00,ARNA,negative
94229.0,﻿Shares of several healthcare companies are trading higher with the overall market after the U.S. announced it is excluding and delaying the additional 10% tariff on certain products.,2019-08-13 11:53:00-04:00,ARNA,positive
94230.0,42 Healthcare Stocks Moving In Wednesday's After-Market Session,2019-08-07 21:24:00-04:00,ARNA,neutral
94231.0,"Arena Pharmaceuticals Q2 EPS $(1.24) Misses $(1.08) Estimate, Sales $1M Miss $2.91M Estimate",2019-08-07 16:01:00-04:00,ARNA,negative
94232.0,"The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout",2019-08-07 07:34:00-04:00,ARNA,neutral
94233.0,Stocks That Broke Yearly Highs Thursday Morning,2019-08-01 10:19:00-04:00,ARNA,negative
94234.0,Stocks That Managed to Breach 52-Week Highs Wednesday Morning,2019-07-31 11:01:00-04:00,ARNA,neutral
94235.0,40 Healthcare Stocks Moving In Friday's After-Market Session,2019-07-29 04:25:00-04:00,ARNA,neutral
94236.0,Arena Pharma Reports First Patient Dosed In CAPTIVATE Phase 2 Trial Evaluation Olorinab In Abdominal Pain Associated with IBS,2019-07-25 08:48:00-04:00,ARNA,negative
94237.0,Arena Pharmaceuticals Option Alert: Aug 16 $70 Calls at the Ask: 1500 @ $0.7 vs 29 OI; Earnings 8/5 After Close [est] Ref=$61.08,2019-07-17 14:46:00-04:00,ARNA,positive
94238.0,"Shares of several healthcare companies are trading lower after Trump on Friday said he was preparing an executive order declaring a 'favored nations clause' for drug prices, lowering the price that consumers will pay prescription drugs.",2019-07-08 12:55:00-04:00,ARNA,positive
94239.0,"The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight",2019-07-05 08:55:00-04:00,ARNA,negative
94240.0,"The Daily Biotech Pulse: Celyad To Advance Leukemia Drug To Clinical Trial, Positive Data For Teva's Migraine Drug",2019-07-02 07:29:00-04:00,ARNA,positive
94241.0,Arena Pharmaceuticals Announces First Subject Dosed in ELEVATE UC 52 Global Phase 3 Trial Evaluating Etrasimod in Ulcerative Colitis,2019-06-17 08:31:00-04:00,ARNA,neutral
94242.0,Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico has renewed trade optimism and lifted economic outlook.,2019-06-04 13:07:00-04:00,ARNA,positive
94243.0,"Jim Cramer Shares His Thoughts On Arena Pharmaceuticals, Yext And More",2019-05-20 07:54:00-04:00,ARNA,positive
94244.0,"The Daily Biotech Pulse: FDA Nod For Roche, Trial Results For Agios, Iovance And MacroGenics",2019-05-16 07:40:00-04:00,ARNA,neutral
94245.0,"The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa's Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi",2019-05-15 07:50:00-04:00,ARNA,negative
94246.0,58 Biggest Movers From Yesterday,2019-05-15 05:09:00-04:00,ARNA,neutral
94247.0,"Shares of several healthcare companies are trading lower amid continued trade dispute between the US and China. Also, the United States filed a lawsuit against drug manufacturers alleging price fixing.",2019-05-13 10:35:00-04:00,ARNA,negative
94248.0,"Arena Pharmaceuticals Q1 EPS $12.1 Misses $13.89 Estimate, Sales $801.057M Miss $801.7M Estimate",2019-05-08 16:38:00-04:00,ARNA,negative
94249.0,"The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split",2019-05-08 07:53:00-04:00,ARNA,negative
94250.0,"Earnings Scheduled For May 8, 2019",2019-05-08 04:39:00-04:00,ARNA,neutral
94251.0,Shares of several healthcare companies are trading lower on continued uncertainty over healthcare policy as well as concerns over the medicare-for-all proposals among 2020 candidates.,2019-04-30 12:16:00-04:00,ARNA,negative
94252.0,The New Cannabis ETF Is Already Making Additions,2019-04-24 11:30:00-04:00,ARNA,neutral
94253.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,2019-04-18 10:51:00-04:00,ARNA,negative
94254.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,2019-04-17 10:31:00-04:00,ARNA,negative
94255.0,"Credit Suisse Maintains Outperform on Arena Pharmaceuticals, Raises Price Target to $77",2019-04-03 09:51:00-04:00,ARNA,positive
94256.0,Arena Pharmaceuticals Highlights Presentation Of New Phase 2 Data For Etrasimod And Olorinab At The 14th Congress Of European Crohn's And Colitis Organisation,2019-03-08 08:39:00-05:00,ARNA,neutral
94257.0,"Arena Pharma Says New Data For Etrasimod, Olorinab To Be Presented At Congress Of European Crohn's, Colitis Organisation",2019-03-08 08:34:00-05:00,ARNA,neutral
94258.0,"Arena Pharmaceuticals Q4 EPS $1.35 May Not Compare To $(0.76) Estimate, Sales $8.6M Beat $3.6M Estimate",2019-02-26 16:45:00-05:00,ARNA,neutral
94259.0,"The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote",2019-02-26 07:56:00-05:00,ARNA,positive
94260.0,"The Daily Biotech Pulse: Intuitive Surgical Earnings, Corbus To Offer Shares, Eton In-Licenses Neurologic Drug",2019-01-25 07:38:00-05:00,ARNA,positive
94261.0,Arena Pharmaceuticals Announces Closing of Global License Agreement with United Therapeutics for Ralinepag,2019-01-25 04:45:00-05:00,ARNA,positive
94262.0,65 Biggest Movers From Yesterday,2019-01-08 05:16:00-05:00,ARNA,neutral
94263.0,42 Stocks Moving In Monday's Mid-Day Session,2019-01-07 13:49:00-05:00,ARNA,neutral
94264.0,Arena Pharmaceuticals shares are trading higher after the company reported positive long-term data from the open-label extension of the Phase 2 OASIS trial.,2019-01-07 10:43:00-05:00,ARNA,positive
94265.0,Arena Pharmaceuticals Reports 'Positive' Long-Term Data from the Open-Label Extension of the Phase 2 OASIS Trial Evaluating Etrasimod for Treatment of Ulcerative Colitis,2019-01-07 08:48:00-05:00,ARNA,neutral
94266.0,"Berenberg Initiates Coverage On Arena Pharmaceuticals with Buy Rating, Announces $55 Price Target",2018-12-13 09:45:00-05:00,ARNA,neutral
94267.0,"Credit Suisse Maintains Outperform on Arena Pharmaceuticals, Raises Price Target to $61",2018-11-19 10:06:00-05:00,ARNA,positive
94268.0,12 NYSE- And NASDAQ-Listed Stocks With Cannabis Exposure,2018-11-16 09:00:00-05:00,ARNA,neutral
94269.0,64 Biggest Movers From Yesterday,2018-11-16 04:58:00-05:00,ARNA,neutral
94270.0,45 Stocks Moving In Thursday's Mid-Day Session,2018-11-15 12:38:00-05:00,ARNA,neutral
94271.0,Mid-Day Market Update: Smart & Final Stores Rises Following Strong Q3 Earnings; Remark Holdings Shares Drop,2018-11-15 12:09:00-05:00,ARNA,positive
94272.0,Mid-Morning Market Update: Markets Open Lower; Walmart Profit Tops Expectations,2018-11-15 10:21:00-05:00,ARNA,positive
94273.0,34 Stocks Moving In Thursday's Pre-Market Session,2018-11-15 08:02:00-05:00,ARNA,neutral
94274.0,"UPDATE: Arena Will Grant United Therapeutics Exclusive Global Rights To Develop, Manufacture, Commercialize Ralinepag; Arena Will Receive Up To $1.2B",2018-11-15 07:02:00-05:00,ARNA,positive
94275.0,"Arena Pharma, United Therapeutics Report Global License Deal For Ralinepag",2018-11-15 07:01:00-05:00,ARNA,positive
94276.0,34 Stocks Moving In Friday's Pre-Market Session,2018-11-09 08:15:00-05:00,ARNA,neutral
94277.0,"Arena Pharmaceuticals Q3 EPS $(0.70) Beats $(0.74) Estimate, Sales $3.6M Beat $2.32M Estimate",2018-11-07 16:36:00-05:00,ARNA,neutral
94278.0,"The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie",2018-11-07 07:50:00-05:00,ARNA,negative
94279.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,ARNA,neutral
94280.0,"The Daily Biotech Pulse: Affimed's Cancer Drug Placed On Clinical Hold, Celgene's Positive Scalp Psoriasis Trial",2018-10-09 08:03:00-04:00,ARNA,negative
94281.0,"Arena Pharmaceuticals Reports Long-Term Data From Ongoing Open-Label Extension Of Phase 2 Trial Evaluating Ralinepag In Pulmonary Arterial Hypertension; DRalinepag Demonstrated Durable, Long-Term Improvements In PVR And 6MWD",2018-10-02 08:08:00-04:00,ARNA,positive
94282.0,"The Daily Biotech Pulse: Syndax Lung Cancer Trial Disappoints, Gemphire To Trim Workforce, Opiant's Offering",2018-09-25 08:30:00-04:00,ARNA,negative
94283.0,Arena Pharma Reports Statistically Significant Positive Phase 2a Results for Olorinab,2018-09-24 16:02:00-04:00,ARNA,positive
94284.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-09-23 16:10:00-04:00,ARNA,neutral
94285.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-08-10 16:31:00-04:00,ARNA,positive
94286.0,7 Stocks Moving In Monday's After-Hours Session,2018-08-06 17:00:00-04:00,ARNA,neutral
94287.0,"Arena Pharmaceuticals Q2 EPS $(0.65) Misses $(0.64) Estimate, Sales $3.994M Beat $2.91M Estimate",2018-08-06 16:04:00-04:00,ARNA,negative
94288.0,Arena Pharmaceuticals Q2 Earnings Outlook,2018-08-06 08:36:00-04:00,ARNA,neutral
94289.0,Eisai Announces Positive Topline Results Obtained from Large-Scale Cardiovascular Outcomes Trial of Anti-Obesity Agent BELVIQ,2018-07-18 05:13:00-04:00,ARNA,positive
94290.0,"Benzinga's Daily Biotech Pulse: Mylan's Neulasta Biosimilar Approved, Portola's CEO To Retire, Regenxbio To Join S&P SmallCap Index",2018-06-05 08:05:00-04:00,ARNA,positive
94291.0,"Benzinga's Daily Biotech Pulse: AstraZeneca's Q1, Novartis-Amgen Migraine Drug Approved",2018-05-18 08:00:00-04:00,ARNA,positive
94292.0,"Benzinga's Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway",2018-05-09 07:48:00-04:00,ARNA,neutral
94293.0,"Arena Pharmaceuticals Q1 EPS $(0.80) Misses $(0.68) Estimate, Sales $1.8M Miss $2.94M Estimate",2018-05-08 16:02:00-04:00,ARNA,negative
94294.0,"Benzinga's Daily Biotech Pulse: Valeant Earnings, Lipocine's FDA Watch, Invivo CFO Departure",2018-05-08 07:55:00-04:00,ARNA,neutral
94295.0,"The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More",2018-05-06 18:19:00-04:00,ARNA,neutral
94296.0,"Arena Pharmaceuticals, Outpost Medicine Enter into Licensing Agreement for Undisclosed Novel Compound; Arena To Receive $3M In Cash And Equity And Is Eligible To Receive ~$100M In Milestone Payments And Up To Low Double-Digit Royalty",2018-05-01 08:37:00-04:00,ARNA,positive
94297.0,"Arena Pharmaceuticals Prices 8,5M Share Public Offering of Common Stock @$41.50/Share",2018-03-22 03:57:00-04:00,ARNA,positive
94298.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Wed., Mar. 21",2018-03-21 10:14:00-04:00,ARNA,positive
94299.0,33 Biggest Movers From Yesterday,2018-03-21 05:30:00-04:00,ARNA,neutral
94300.0,Arena Pharma Announces 7.5M Share Common Stock Offering,2018-03-20 16:01:00-04:00,ARNA,positive
94301.0,"Arena Pharmaceuticals Shares Up 26.6% After Positive Etrasimod Trial Results, Needham Upgrade To Buy",2018-03-20 15:03:00-04:00,ARNA,positive
94302.0,"Benzinga Pro's Most-Searched Tickers For Tues., Mar. 20",2018-03-20 14:49:00-04:00,ARNA,neutral
94303.0,Mid-Afternoon Market Update: MuleSoft Gains Following Report Of Takeover Interest From Salesforce; Proteostasis Therapeutics Shares Slide,2018-03-20 14:34:00-04:00,ARNA,positive
94304.0,28 Stocks Moving In Tuesday's Mid-Day Session,2018-03-20 13:46:00-04:00,ARNA,neutral
94305.0,Mid-Day Market Update: Crude Oil Up 2.5%; Arena Pharmaceuticals Shares Spike Higher,2018-03-20 12:35:00-04:00,ARNA,negative
94306.0,Mid-Morning Market Update: Markets Gain; Oracle Shares Fall Following Q3 Results,2018-03-20 10:35:00-04:00,ARNA,positive
94307.0,Here's Why Arena Pharmaceuticals Jumped 30% Today,2018-03-20 10:24:00-04:00,ARNA,neutral
94308.0,"Benzinga's Top Upgrades, Downgrades For March 20, 2018",2018-03-20 10:10:00-04:00,ARNA,positive
94309.0,15 Stocks Moving In Tuesday's Pre-Market Session,2018-03-20 08:20:00-04:00,ARNA,neutral
94310.0,Needham Upgrades Arena Pharmaceuticals to Buy,2018-03-20 07:48:00-04:00,ARNA,neutral
94311.0,A Peek Into The Markets: U.S. Stock Futures Down; Fed Meeting In Focus,2018-03-20 06:54:00-04:00,ARNA,neutral
94312.0,"7 Stocks To Watch For March 20, 2018",2018-03-20 04:47:00-04:00,ARNA,neutral
94313.0,7 Stocks Moving In Monday's After-Hours Session,2018-03-19 18:03:00-04:00,ARNA,neutral
94314.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Mon., Mar. 19",2018-03-19 17:25:00-04:00,ARNA,positive
94315.0,"Arena Pharmaceuticals Shares Up 35% After Hours Following News Phase 2 OASIS Trial For Ulcerative Colitis Treatment Met Primary, All Secondary Endpoints; Co. Intends To Initiate Phase 3 Trial",2018-03-19 16:40:00-04:00,ARNA,positive
94316.0,"Arena Pharma Shares Resume Trade, Now Up 38.8%",2018-03-19 16:38:00-04:00,ARNA,positive
94317.0,Arena Pharma Shares To Resume Trade At 4:30 p.m. EDT,2018-03-19 16:11:00-04:00,ARNA,positive
94318.0,"Arena Pharmaceuticals Initiates Phase 3 Program In Ulcerative Colitis, Has Conf. Call Today At 4:30 pm ET",2018-03-19 16:04:00-04:00,ARNA,neutral
94319.0,Arena Pharmaceuticals OASIS Trial Met Primary And All Secondary Endpoints With Statistical Signficance,2018-03-19 16:03:00-04:00,ARNA,neutral
94320.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-03-16 16:16:00-04:00,ARNA,positive
94321.0,"Arena Pharma Reports Q4 EPS $(0.35) vs $(0.59) Est., Sales $15.4M vs $7.6M Est.",2018-03-14 08:04:00-04:00,ARNA,neutral
94322.0,"Adam Feuerstein Tweets: $ARNA Q4 earnings call is tomorrow morning. Just guessing here, but won't be surprised if we see the etrasimod ph2 ulcerative colitis data.",2018-03-13 09:40:00-04:00,ARNA,negative
94323.0,Arena Pharmaceuticals Q4 Earnings Preview,2018-03-13 07:50:00-04:00,ARNA,neutral
94324.0,"Earnings Scheduled For March 13, 2018",2018-03-13 05:20:00-04:00,ARNA,neutral
94325.0,"The Week Ahead In Biotech: Earnings, PDUFA Dates And More",2018-03-11 16:58:00-04:00,ARNA,neutral
94326.0,7 Biotech Stocks With Clinical Trial Outcomes In March,2018-03-05 12:01:00-05:00,ARNA,neutral
94327.0,UPDATE: Arena Pharma Says 'Healthy volunteers did not exhibit psychotropic effects commonly seen with cannabinoids',2018-03-01 08:35:00-05:00,ARNA,positive
94328.0,UPDATE: Arena Pharma Says 'Data from Phase 1 study of APD371 in healthy volunteers demonstrate safety and tolerability',2018-03-01 08:34:00-05:00,ARNA,positive
94329.0,"Arena Pharma Reports Will Present Phase 1, Preclinical Data On APD371 In Development For Treatment Of Pain Associated With Crohn's Disease AT APSASS",2018-03-01 08:34:00-05:00,ARNA,negative
94330.0,"Regulatory Concern For Celgene's Ozanimod Could Be Big For Arena Pharma, Novartis",2018-02-28 08:26:00-05:00,ARNA,neutral
94331.0,Benzinga Pro's 5 Stocks To Watch,2018-02-28 08:00:00-05:00,ARNA,neutral
94332.0,"Arena Pharma Shares Up 2% Premarket Following Concerning Regulatory News Related To Celgene's Ozanimod, A Competitor To Arena's Etrasimod",2018-02-28 06:26:00-05:00,ARNA,positive
94333.0,"Citigroup Maintains Buy on Arena Pharmaceuticals, Raises price target to $55.00",2018-02-27 09:19:00-05:00,ARNA,neutral
94334.0,"13F From Perceptive Advisors Late Wednesday Shows Increased Stake In Abiomed, Neurocrine Biosciences, VBI Vaccines; New Stake In Agile Therapeutics, Amgen, bluebird bio, Arena Pharma, Revance Therapeutics; Exited Stake In Achaogen, OraSure Technologies",2018-02-15 10:41:00-05:00,ARNA,positive
94335.0,"Credit Suisse Initiates Coverage On Arena Pharmaceuticals with Outperform Rating, Announces $44.00 Price Target",2018-01-17 16:53:00-05:00,ARNA,positive
94336.0,46 Biggest Movers From Yesterday,2018-01-12 05:25:00-05:00,ARNA,neutral
94337.0,8 Stocks Moving In Thursday's After-Hours Session,2018-01-11 17:22:00-05:00,ARNA,neutral
94338.0,Orexigen Struggles As Contrave Commercialization Costs Rise,2018-01-05 10:54:00-05:00,ARNA,negative
94339.0,40 Biggest Movers From Yesterday,2018-01-04 05:30:00-05:00,ARNA,neutral
94340.0,Arena Pharma Upgraded Ahead Of Clinical Data Release,2018-01-03 16:47:00-05:00,ARNA,neutral
94341.0,30 Stocks Moving In Wednesday's Mid-Day Session,2018-01-03 12:26:00-05:00,ARNA,neutral
94342.0,"Benzinga's Top Upgrades, Downgrades For January 3, 2018",2018-01-03 09:14:00-05:00,ARNA,positive
94343.0,Wells Fargo Upgrades Arena Pharmaceuticals to Outperform,2018-01-03 07:29:00-05:00,ARNA,positive
94344.0,7 Best Marijuana Stocks That Blazed A Trail In 2017,2017-12-23 10:41:00-05:00,ARNA,positive
94345.0,"Arena Pharmaceuticals, Everest Medicines Enter into Development and Commercialization Partnership for Ralinepag and Etrasimod in China; Arena Receives Low Double-Digit Royalties, $12M Upfront Payment, And Is Eligible For $212M In Milestone Payments",2017-12-05 08:33:00-05:00,ARNA,negative
94346.0,"Arena Pharmaceuticals Completes Full Enrollment in Etrasimod Phase 2 Clinical Study for Ulcerative Colitis, Data Readout Expected in Q1 2018",2017-11-10 11:32:00-05:00,ARNA,neutral
94347.0,"Arena Pharma Reports Q3 EPS $(0.86) vs $(0.67) Est., Sales $7.9M vs $5.48M Est.",2017-11-07 16:41:00-05:00,ARNA,neutral
94348.0,"Investing In Marijuana: Cannabis Industry Raises Hit $1.8 Billion, Up 150% Year Over Year",2017-10-16 08:41:00-04:00,ARNA,neutral
94349.0,"Jim Cramer Gives His Opinion On Allergan, USG And Arena Pharmaceuticals",2017-09-12 08:01:00-04:00,ARNA,neutral
94350.0,22 Stocks Moving In Friday's Pre-Market Session,2017-08-11 08:23:00-04:00,ARNA,neutral
94351.0,Mid-Afternoon Market Update: Crude Oil Up 1%; DragonWave Shares Plunge,2017-07-13 14:36:00-04:00,ARNA,negative
94352.0,10 Biggest Mid-Day Losers For Thursday,2017-07-13 12:39:00-04:00,ARNA,negative
94353.0,Mid-Day Market Update: Yandex Jumps Following Announcement Of Deal With Uber; Amicus Therapeutics Shares Drop,2017-07-13 12:04:00-04:00,ARNA,positive
94354.0,22 Stocks Moving In Thursday's Pre-Market Session,2017-07-13 08:04:00-04:00,ARNA,neutral
94355.0,10 Biggest Mid-Day Losers For Wednesday,2017-07-12 12:50:00-04:00,ARNA,negative
94356.0,Arena Pharmaceuticals Announces Proposed Public Offering Of $150M Of Shares,2017-07-11 16:09:00-04:00,ARNA,positive
94357.0,"Filing From Arena Pharma Shows Registration For Common Stock Offering, Amount Not Disclosed",2017-07-11 16:04:00-04:00,ARNA,neutral
94358.0,Mid-Afternoon Market Update: Crude Oil Up 1.5%; VOXX International Shares Plummet,2017-07-11 14:30:00-04:00,ARNA,negative
94359.0,12 Biggest Mid-Day Gainers For Tuesday,2017-07-11 12:24:00-04:00,ARNA,neutral
94360.0,Mid-Day Market Update: Halcon Resources Jumps After Announcing Sale of Williston Basin Assets; Shiloh Industries Shares Slide,2017-07-11 12:00:00-04:00,ARNA,positive
94361.0,Why Arena Is Taking Center Stage Today,2017-07-11 11:53:00-04:00,ARNA,neutral
94362.0,Mid-Morning Market Update: Markets Mostly Flat; PepsiCo Profit Tops Expectations,2017-07-11 10:10:00-04:00,ARNA,positive
94363.0,20 Stocks Moving In Tuesday's Pre-Market Session,2017-07-11 08:10:00-04:00,ARNA,neutral
94364.0,Arena Pharmaceuticals +41.38% Premarket @$26.00; Co Reported Positive Topline Phase 2 Results Monday for Ralinepag in Patients with Pulmonary Arterial Hypertension,2017-07-11 07:16:00-04:00,ARNA,positive
94365.0,UPDATE: Arena Pharma On Ralinepag Phase 2 Results: 'Safety data consistent with other drugs acting through the prostacyclin receptor-mediated effects',2017-07-10 16:15:00-04:00,ARNA,positive
94366.0,Arena Pharma Offers Topline Phase 2 Results For Ralinepag In Patients With Pulmonary Arterial Hypertension: 'Primary efficacy analysis successful - significant improvement in pulmonary vascular resistance',2017-07-10 16:15:00-04:00,ARNA,positive
94367.0,12 Biggest Mid-Day Gainers For Friday,2017-07-07 12:30:00-04:00,ARNA,neutral
94368.0,"Benzinga's Top Upgrades, Downgrades For July 7, 2017",2017-07-07 09:23:00-04:00,ARNA,positive
94369.0,"Arena Upgraded, Analyst Sees 44% Upside",2017-07-07 09:09:00-04:00,ARNA,neutral
94370.0,"Adam Feuerstein Tweets: I didn't ""bash"" $ARNA today. In fact, I wrote something kinda nice. Shocked? —> statnews.com/2017/07/06/are…",2017-07-06 08:09:00-04:00,ARNA,positive
94371.0,15 Biggest Mid-Day Gainers For Tuesday,2017-06-27 12:31:00-04:00,ARNA,neutral
94372.0,"Benzinga's Top Upgrades, Downgrades For June 27, 2017",2017-06-27 09:27:00-04:00,ARNA,positive
94373.0,"Citigroup Initiates Coverage On Arena Pharmaceuticals with Buy Rating, Announces $23.00 Price Target",2017-06-27 06:35:00-04:00,ARNA,neutral
94374.0,Mid-Afternoon Market Update: Portola Climbs On FDA Approval For Bevyxxa; American Software Shares Plunge,2017-06-23 14:30:00-04:00,ARNA,positive
94375.0,Mid-Day Market Update: Bed Bath & Beyond Drops Following Disappointing Earnings; Synchronoss Technologies Shares Surge,2017-06-23 12:03:00-04:00,ARNA,negative
94376.0,Mid-Morning Market Update: Markets Mostly Flat; BlackBerry Sales Miss Views,2017-06-23 10:15:00-04:00,ARNA,negative
94379.0,Mid-Afternoon Market Update: Fang Drops After Q1 Results; Invivo Therapeutics Shares Surge,2017-06-20 14:33:00-04:00,ARNA,positive
94380.0,"Benzinga's Top Upgrades, Downgrades For June 15, 2017",2017-06-15 09:29:00-04:00,ARNA,positive
94381.0,"Cantor Fitzgerald Initiates Coverage On Arena Pharmaceuticals with Overweight Rating, Announces $4.00 Price Target",2017-06-15 07:13:00-04:00,ARNA,negative
94382.0,Arena Pharmaceuticals Approves 1-for-10 Reverse Stock Split,2017-06-14 16:02:00-04:00,ARNA,positive
94385.0,Option Alert: Arena Pharma Oct 2.0 Calls Sweep: 500 @  ASK  $0.19: 585 traded vs 1015 OI:  Earnings 8/7 After Close (est)  $1.39 Ref,2017-06-05 14:03:00-04:00,ARNA,positive
94386.0,Arena Pharma Could Be Developing Several Best-In-Class Agents,2017-05-19 14:59:00-04:00,ARNA,neutral
94387.0,15 Biggest Mid-Day Gainers For Friday,2017-05-19 12:42:00-04:00,ARNA,neutral
94388.0,"Benzinga's Top Upgrades, Downgrades For May 19, 2017",2017-05-19 09:41:00-04:00,ARNA,positive
94389.0,"Leerink Swann Initiates Coverage On Arena Pharmaceuticals with Outperform Rating, Announces $5.00 Price Target",2017-05-19 07:59:00-04:00,ARNA,neutral
94390.0,"Arena Pharmaceuticals Reports Q1 EPS $(0.09) vs $(0.07) Est., Sales $6.6M vs $8.07M Est.",2017-05-09 16:33:00-04:00,ARNA,neutral
94391.0,Mid-Afternoon Market Update: GNC Gains On Upbeat Earnings; Barracuda Shares Drop,2017-04-18 15:08:00-04:00,ARNA,positive
94392.0,15 Biggest Mid-Day Losers For Tuesday,2017-04-18 13:02:00-04:00,ARNA,negative
94393.0,Mid-Day Market Update: Dow Drops Over 100 Points; Arena Pharmaceuticals Shares Plummet,2017-04-18 12:01:00-04:00,ARNA,positive
94394.0,Mid-Morning Market Update: Markets Open Lower; Goldman Sachs Earnings Miss Estimates,2017-04-18 10:00:00-04:00,ARNA,negative
94395.0,Arena Pharmaceuticals Prices 60M Share Offering @$1.15/Share,2017-04-18 04:04:00-04:00,ARNA,positive
94396.0,"Arena Pharma Reports Offering of Common Stock, No Amount Disclosed",2017-04-17 16:01:00-04:00,ARNA,negative
94397.0,18 Biggest Mid-Day Gainers For Wednesday,2017-03-15 12:38:00-04:00,ARNA,neutral
94398.0,20 Stocks Moving In Wednesday's Pre-Market Session,2017-03-15 08:17:00-04:00,ARNA,neutral
94399.0,"Arena Pharma Shares Tick to Morning Highs Over $1.80 Level, Now Indicated at $1.82, Up 28.2%",2017-03-15 08:06:00-04:00,ARNA,positive
94400.0,"Arena Pharma Reports Q4 EPS $0.16 vs $(0.13) in Same Qtr. Last Year, Sales $85.4M vs $7.75M YoY",2017-03-14 16:03:00-04:00,ARNA,neutral
94401.0,"Earnings Scheduled For March 14, 2017",2017-03-14 04:44:00-04:00,ARNA,neutral
94402.0,"Arena Pharmaceuticals, Eisai Amend Marketing and Supply Agreement for BELVIQ Globally",2017-01-04 16:15:00-05:00,ARNA,positive
94403.0,"Eisai, Arena Pharmaceuticals Announce Regulatory Approval of BELVIQ",2016-12-19 13:30:00-05:00,ARNA,positive
94404.0,Arena Pharma Completes Enrollment of Phase 2 Trial,2016-12-07 08:30:00-05:00,ARNA,neutral
94405.0,"Smoke Rising: As More States Legalize, Marijuana Investing Opportunity Grows",2016-12-02 10:01:00-05:00,ARNA,positive
94406.0,"Arena Pharmaceuticals Reports Q3 EPS $(0.05) vs. Est. $(0.07), Rev. $19.2M vs. Est. $13.99M",2016-11-07 16:51:00-05:00,ARNA,neutral
94407.0,Arena Pharmaceuticals Reports Acceptance of Late Breaking Etrasimod Abstract at the United European Gastroenterology Week (UEGW) Meeting,2016-10-11 08:37:00-04:00,ARNA,positive
94408.0,Arena Pharma Sells off to Low of $1.84 on Heavy Volume,2016-10-10 12:42:00-04:00,ARNA,negative
94409.0,"Arena Pharma, Eisai Report Availability of Once-Daily BELVIQ ER Tablets",2016-10-03 08:07:00-04:00,ARNA,neutral
94410.0,Watch These 5 Huge Call Purchases In Thursday Trade,2016-09-29 02:30:00-04:00,ARNA,positive
94411.0,Option Alert: ARNA Apr17 3.0 Calls Sweep: 500 @  ASK  $0.225: 500 traded vs 26 OI:  Earnings 11/8  $1.78 Ref,2016-09-28 14:48:00-04:00,ARNA,positive
94412.0,FBR Capital Initiates Coverage on Arena Pharmaceuticals at Outperform,2016-09-15 09:41:00-04:00,ARNA,neutral
94413.0,"Arena Pharmaceuticals, Eisai Received Paragraph IV Certification Notification with Respect to Patents for BELVIQ Listed in FDA's Orange Book",2016-08-25 06:11:00-04:00,ARNA,positive
94414.0,Arena Pharmaceuticals Names Vincent Aurentz Chief Business Officer,2016-08-15 07:06:00-04:00,ARNA,neutral
94415.0,"Arena Pharmaceuticals Reports Q2 EPS $(0.11) vs. Est. $(0.10), Rev. $9.512M vs. Est. $10.4M",2016-08-08 16:38:00-04:00,ARNA,neutral
94416.0,"Earnings Scheduled For August 8, 2016",2016-08-08 04:12:00-04:00,ARNA,neutral
94417.0,Eisai And Arena Pharmaceuticals Get FDA Approval For BELVIQ XR Extended-Release Tablets,2016-07-19 10:20:00-04:00,ARNA,positive
94418.0,"Eisai Inc. and Arena Pharmaceuticals Announce FDA Approval of BELVIQ XR, Arena To Receive $10M Milestone Payment",2016-07-19 08:28:00-04:00,ARNA,positive
94419.0,Link Circulating Shows  FDA Approves Arena Pharmaceuticals Belviq XR Formulatio,2016-07-18 13:30:00-04:00,ARNA,positive
94420.0,10 Biggest Mid-Day Gainers For Thursday,2016-07-14 12:45:00-04:00,ARNA,neutral
94421.0,"Eisai, Arena Pharmaceuticals Get Regulatory Approval For VENESPRI In Mexico",2016-07-14 11:51:00-04:00,ARNA,positive
94422.0,12 Stocks Moving In Thursday's Pre-Market Session,2016-07-14 08:27:00-04:00,ARNA,neutral
94423.0,"Eisai, Arena Pharma Report Regulatory Approval of VENESPRI in Mexico",2016-07-14 08:05:00-04:00,ARNA,positive
94424.0,Arena Pharma Shares Indicated Down ~$0.10 to ~$1.60,2016-06-30 16:40:00-04:00,ARNA,positive
94425.0,"Arena Pharma Shares Open for Trade; However, New Print Not Yet Shown",2016-06-30 16:35:00-04:00,ARNA,positive
94426.0,UPDATE: Arena Says Will Incur ~$6.1M Charge in Q2,2016-06-30 16:14:00-04:00,ARNA,neutral
94427.0,Arena Shares to Resume Trade at 4:35 p.m. EDT,2016-06-30 16:12:00-04:00,ARNA,positive
94428.0,"UPDATE: Arena Sees Reducing Annualized Capex by $17M for Personnel, $6-$8M for Other Operating Expenses",2016-06-30 16:07:00-04:00,ARNA,neutral
94429.0,"UPDATE: Arena Will Cut US Workforce by ~100 Employees, or ~73%",2016-06-30 16:07:00-04:00,ARNA,negative
94430.0,Arena Pharma Announces Implementation of Added Cost Reductions to Streamline Operations,2016-06-30 16:06:00-04:00,ARNA,neutral
94431.0,Adam Feuerstein @adamfeuerstein Tweet:  $ARNA halt could be tied to reports of Belviq hypersensitivity reactions —> fda.gov/Drugs/Guidance…,2016-06-30 16:02:00-04:00,ARNA,neutral
94432.0,Arena Pharma Shares Halted News Pending,2016-06-30 16:00:00-04:00,ARNA,positive
94433.0,Arena Pharmaceuticals Hires Kevin Lind As CFO,2016-06-15 11:57:00-04:00,ARNA,neutral
94434.0,Arena Pharma Names Kevin Lind CFO,2016-06-15 07:00:00-04:00,ARNA,neutral
94435.0,Arena Pharmaceuticals Files $250M Mixed Shelf Offering,2016-06-14 16:36:00-04:00,ARNA,neutral
94436.0,Arena Pharmaceuticals Reports Chief Medical Officer Dr. William Shanahan Jr. Terminated Without Cause Effective Immediately,2016-06-13 16:50:00-04:00,ARNA,negative
94437.0,Arena Gets USAN Approval Of Nonproprietary Name 'Etrasimod' For Its Drug Candidate APD334,2016-06-13 08:55:00-04:00,ARNA,positive
94438.0,"Arena Pharma Reports Q1 EPS $(0.09) vs $(0.10) Est., Sales $9.02M vs $9.8M Est.",2016-05-09 16:08:00-04:00,ARNA,neutral
94439.0,"Arena Pharma Names Amit Munshi Pres, CEO",2016-05-09 16:08:00-04:00,ARNA,neutral
94440.0,Mid-Afternoon Market Update: Crude Oil Up 4.5%; Horizon Pharma Shares Tumble,2016-04-12 14:35:00-04:00,ARNA,negative
94441.0,Mid-Day Market Update: Dow Jumps 150 Points; Juniper Shares Drop On Weak Forecast,2016-04-12 12:12:00-04:00,ARNA,negative
94442.0,Mid-Morning Market Update: Markets Open Higher; Alcoa Revenue Misses Views,2016-04-12 09:50:00-04:00,ARNA,negative
94443.0,10 Stocks Moving In Tuesday's Pre-Market Session,2016-04-12 08:30:00-04:00,ARNA,neutral
94444.0,Arena Pharma Reports Results from Phase 1b Trial of APD371,2016-04-12 08:04:00-04:00,ARNA,neutral
94445.0,Option Alert: ARNA Jan17 5.0 Calls: 800 @  ASK  $0.23: 800 traded vs 10k OI:  Earnings 5/9  $1.96 Ref,2016-03-30 09:57:00-04:00,ARNA,positive
94446.0,Arena Pharma Moving Higher After Open; Trades Citing Stock as Play on GW Pharma News,2016-03-14 09:34:00-04:00,ARNA,positive
94447.0,"Arena Pharma Reports Q4 EPS $(0.13), Inline, Sales $7.8M vs $8.3M Est.",2016-02-29 16:01:00-05:00,ARNA,neutral
94448.0,"Earnings Scheduled For February 29, 2016",2016-02-29 04:04:00-05:00,ARNA,neutral
94449.0,"Boehringer Ingelheim, Arena Pharma. Partner For Advanced Research In Schizophrenia; Arena Eligible For Payments Up To $262M Based On Milestone Success",2016-01-12 16:07:00-05:00,ARNA,positive
94450.0,"UPDATE: Kyle Bass Says Patent Battle In Pharma Industry Has 'not been fun', Says Global Pharma Co's Have Gross Margins Larger Than Google",2016-01-02 13:15:00-05:00,ARNA,negative
94451.0,6 Charts Costa Is Watching,2015-12-23 12:52:00-05:00,ARNA,neutral
94452.0,Option Alert: ARNA Jan16 7.0 Calls Sweep: 1000 @  ASK  $0.01: 1000 traded vs 27k OI: $1.88 Ref,2015-12-09 13:46:00-05:00,ARNA,positive
94453.0,Morning Market Gainers,2015-12-01 09:43:00-05:00,ARNA,neutral
94454.0,Benzinga's Top #PreMarket Gainers,2015-12-01 08:16:00-05:00,ARNA,positive
94455.0,Arena Pharma +15% @$2.75 Premarket as FDA Accepts NDA for Once-Daily Formulation of Belviq,2015-12-01 08:13:00-05:00,ARNA,positive
94456.0,Eisai Announces FDA Accepts NDA for Once-Daily Formulation of Antiobesity Agent Belviq,2015-12-01 04:12:00-05:00,ARNA,positive
94457.0,Benzinga's Top #PreMarket Gainers,2015-11-30 08:15:00-05:00,ARNA,positive
94458.0,"Eisai, Arena Pharma Report FDA Acceptance of NDA for ER Formulation of Lorcaserin",2015-11-30 08:01:00-05:00,ARNA,positive
94459.0,"Keep an Eye on These 5 Stocks for November 11, 2015",2015-11-11 05:01:00-05:00,ARNA,neutral
94460.0,"Amira Nature Foods, AlarmCom, Flotek Moving In Tuesday's After Hours Session",2015-11-10 17:05:00-05:00,ARNA,neutral
94461.0,Arena Pharma shares up 10% following earnings release,2015-11-10 16:27:00-05:00,ARNA,positive
94462.0,Arena Pharma To Reduce Workforce By 35% or 80 Employees,2015-11-10 16:04:00-05:00,ARNA,neutral
94463.0,Arena Pharma Reports Q3 EPS ($0.11) Vs Est ($0.13),2015-11-10 16:00:00-05:00,ARNA,neutral
94464.0,"Earnings Scheduled For November 10, 2015",2015-11-10 04:03:00-05:00,ARNA,neutral
94465.0,Arena Pharmaceuticals Starts a Phase 1b Clinical Trial of APD371,2015-10-29 08:06:00-04:00,ARNA,neutral
94466.0,"Arena Pharma Reports New Strategic Focus, Cost Reduction Plan; to Cut 80 Employees, ~35% of US Headcount",2015-10-27 16:03:00-04:00,ARNA,negative
94467.0,"Monday's After-Hours Movers Led By Du Pont, Arena Pharma, Illumina & Container Store Group",2015-10-05 17:26:00-04:00,ARNA,neutral
94468.0,Arena Pharmaceuticals Announces Retirement of President and CEO Jack Lief,2015-10-05 16:16:00-04:00,ARNA,neutral
94469.0,Fast Money Traders Share Their Under $5 Stock Picks,2015-09-14 06:56:00-04:00,ARNA,positive
94470.0,"Arena Pharma Reports Q2 Loss of $0.11/Share vs Loss of $0.13/Share Est., Sales $9.2M",2015-08-05 16:02:00-04:00,ARNA,negative
94471.0,"Arena Pharmaceuticals Begins a Phase 2 Clinical Trial of APD334, its S1P1 Receptor Modulator for Autoimmune Diseases",2015-07-29 08:02:00-04:00,ARNA,neutral
94472.0,Wednesday's Mid-Day Movers: Does The U.S. Benefit From Iran Deal?; Celgene-Receptos And More,2015-07-15 12:39:00-04:00,ARNA,positive
94473.0,Mid-Morning Market Update: Markets Mostly Higher; Bank Of America Tops Q2 Views,2015-07-15 10:56:00-04:00,ARNA,positive
94474.0,Arena Shares Spike Lower; May be Attributed to Seeking Alpha Article on Adverse Events,2015-07-09 13:15:00-04:00,ARNA,negative
94475.0,"Sportsman's Warehouse, Bob Evans, Peabody Energy Lead Tuesday's After-Hours Movers",2015-06-16 17:52:00-04:00,ARNA,positive
94476.0,"UPDATE: Arena Announces VP, Accounting, Controller, Jennifer Bielasz, 'Will Continue to Play Key Leadership Role' in Co.'s Finance Dept.",2015-06-16 16:33:00-04:00,ARNA,positive
94477.0,Arena Pharma Reports Departure Of CFO Robert Hoffman,2015-06-16 16:30:00-04:00,ARNA,neutral
94478.0,5 New Biotech Developments Worth Watching,2015-05-13 11:35:00-04:00,ARNA,positive
94479.0,"Arena Pharmaceuticals, Roivant Sciences Enter into Collaboration for Nelotanserin; Arena to Receive $4M Upfront Payment,  $41.5M in Milestone Payments",2015-05-11 16:11:00-04:00,ARNA,neutral
94480.0,"Arena Pharma Reports Q1 EPS $(0.10) vs. Est. $(0.14), Rev. $12.3M vs. Est. $10.56M",2015-05-11 16:09:00-04:00,ARNA,neutral
94481.0,Morning Market Gainers,2015-04-29 09:46:00-04:00,ARNA,neutral
94482.0,Benzinga's Top #PreMarket Gainers,2015-04-29 08:15:00-04:00,ARNA,positive
94483.0,Arena Pharmaceuticals Announces Favorable Results from Phase 1 Single-Ascending Dose Clinical Trial of APD371,2015-04-29 08:02:00-04:00,ARNA,positive
94484.0,Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research,2015-04-20 08:38:00-04:00,ARNA,neutral
94485.0,Jefferies: 10 Buyout Targets To Own During The M&A Boom,2015-04-13 16:17:00-04:00,ARNA,neutral
94486.0,"Eisai, Arena Pharmaceuticals Finish Registrational Trials of an Extended Release Formulation of Lorcaserin",2015-04-10 08:04:00-04:00,ARNA,neutral
94487.0,Biotech: Anatomy Of An Investing Mania?,2015-04-07 11:39:00-04:00,ARNA,neutral
94488.0,Arena Pharmaceuticals Awarded Additional Patent for BELVIQ® (lorcaserin HCl) from United States Patent and Trademark Office,2015-04-07 08:04:00-04:00,ARNA,positive
94489.0,Research & Clinical Trials for Prevention of Neurodegeneration Search for Viable Therapeutic Approach for the Treatment of Severe Alzheimer's,2015-04-07 08:01:00-04:00,ARNA,negative
94490.0,Option Alert: Arena Pharma Jan 2016 $4 Call; 1250 Contract Trade above Ask @$1.51,2015-03-20 15:03:00-04:00,ARNA,positive
94491.0,Morning Market Losers,2015-03-03 10:02:00-05:00,ARNA,negative
94492.0,Benzinga's Top #PreMarket Losers,2015-03-03 08:23:00-05:00,ARNA,negative
94493.0,10 Stocks You Should Be Watching Today,2015-03-03 04:32:00-05:00,ARNA,neutral
94494.0,Arena Pharmaceuticals Misses Q4 Expectations,2015-03-02 18:45:00-05:00,ARNA,negative
94495.0,Arena Pharma Reported Q4 Loss of $0.015/Share vs Loss of $0.11/Share Est.,2015-03-02 16:14:00-05:00,ARNA,negative
94496.0,Arena Pharma Reports Q4 Sales $9.19M vs $10.36M Est.,2015-03-02 16:01:00-05:00,ARNA,neutral
94497.0,"Earnings Scheduled For March 2, 2015",2015-03-02 04:44:00-05:00,ARNA,neutral
94498.0,8 Stocks All Investors Should Watch Next Week (In 8 Charts),2015-02-21 13:37:00-05:00,ARNA,neutral
94499.0,Arena Pharmaceuticals Spikes Higher,2015-02-10 14:31:00-05:00,ARNA,neutral
94500.0,"Arena Pharmaceuticals Receives Marketing Approval, Milestone Payment in S. Korea for BELVIQ for Weight Management",2015-02-03 05:04:00-05:00,ARNA,positive
94501.0,Arena Pharma Files To Offer 21M Shares,2015-01-23 16:52:00-05:00,ARNA,positive
94502.0,CNBC's Stock Pops & Drops From January 21,2015-01-21 21:14:00-05:00,ARNA,neutral
94503.0,Mid-Afternoon Market Update: Alnylam Pharmaceuticals Drops Following Equity Offering; Insperity Shares Spike Higher,2015-01-21 15:10:00-05:00,ARNA,positive
94504.0,4 More Biotech Secondaries Traders Are Watching,2015-01-21 13:38:00-05:00,ARNA,neutral
94505.0,Mid-Day Market Update: U.S. Stocks Surge; Netflix Shares Jump On Upbeat Earnings,2015-01-21 12:53:00-05:00,ARNA,positive
94506.0,Mid-Morning Market Update: Markets Mixed; UnitedHealth Profit Tops Expectations,2015-01-21 10:42:00-05:00,ARNA,positive
94507.0,Morning Market Losers,2015-01-21 09:55:00-05:00,ARNA,negative
94508.0,Wednesday Morning Movers: Netflix Flying High,2015-01-21 08:55:00-05:00,ARNA,neutral
94509.0,UPDATE: Arena Sold 21M Shares of Stock,2015-01-21 08:48:00-05:00,ARNA,positive
94510.0,Arena Pharmaceuticals Announces Agreement to Sell Common Stock,2015-01-21 08:45:00-05:00,ARNA,positive
94511.0,Benzinga's Top #PreMarket Losers,2015-01-21 08:23:00-05:00,ARNA,negative
94512.0,Arena Pharmaceuticals Shares Fall 8% Premarket on Announcemtn of Public Offering of Common Stock,2015-01-21 07:37:00-05:00,ARNA,positive
94513.0,Tuesday's After-Hours Movers: Netflix Leads The Pack,2015-01-20 17:25:00-05:00,ARNA,neutral
94514.0,Arena Pharmaceuticals Announces Public Offering of Common Stock,2015-01-20 16:05:00-05:00,ARNA,neutral
94515.0,"8-K from Arena Pharma Shows Co. Expecting Q4 Net Sale of BELVIQ to be Down 35-45% QoQ, Cites Reduced Prescription Growth Rate, Savings Card Program",2015-01-20 09:03:00-05:00,ARNA,positive
94516.0,5 Obesity Stocks Investors Are Watching,2015-01-14 13:55:00-05:00,ARNA,neutral
94517.0,Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3,2015-01-13 10:58:00-05:00,ARNA,neutral
94518.0,Arena Phama Announces Initiation of Phase 2 Trial,2015-01-12 08:02:00-05:00,ARNA,neutral
94519.0,Arena Pharmaceuticals Reports on Eisai's New Marketing Initiatives for BELVIQ,2015-01-09 08:16:00-05:00,ARNA,neutral
94520.0,"Option Alert: Arena Pharmaceuticals Jan $6 Call; 2,151 Contract Trade Above Ask @$0.26; Currently $5.46",2015-01-08 10:01:00-05:00,ARNA,positive
94521.0,Mid-Afternoon Market Update: Dow Jumps Over 200 Points After Fed Minutes; RPM Shares Drop On Downbeat Results,2015-01-07 15:17:00-05:00,ARNA,neutral
94522.0,Mid-Day Market Update: J C Penney Jumps On Strong Holiday Sales; Micron Shares Decline,2015-01-07 13:11:00-05:00,ARNA,positive
94523.0,UPDATE: Arena Pharmaceuticals Shares Rise 65% on Phase 1b APD334 Trial Results,2015-01-07 12:41:00-05:00,ARNA,positive
94524.0,4 Stocks Trending On Social Media This Wednesday,2015-01-07 12:27:00-05:00,ARNA,neutral
94525.0,Mid-Morning Market Update: Markets Surge; Monsanto Profit Tops Estimates,2015-01-07 10:59:00-05:00,ARNA,positive
94526.0,UPDATE: Arena Pharmaceuticals Shares Rise 40% Following Announcement of Positive Results from Phase 1b Clinical Trial Evaluating APD334,2015-01-07 10:41:00-05:00,ARNA,positive
94527.0,Morning Market Gainers,2015-01-07 09:38:00-05:00,ARNA,neutral
94528.0,Wednesday Morning Movers,2015-01-07 09:17:00-05:00,ARNA,neutral
94529.0,Arena Pharmaceuticals Shares Rise 16% Premarket on Positive Results from Phase 1b Clinical Trial Evaluating APD334,2015-01-07 08:44:00-05:00,ARNA,positive
94530.0,Benzinga's Top #PreMarket Gainers,2015-01-07 08:10:00-05:00,ARNA,positive
94531.0,Arena Pharmaceuticals Reports Positive Results From Phase 1b Clinical Trial Evaluating APD334,2015-01-07 08:06:00-05:00,ARNA,positive
94532.0,Orexigen Therapeutics Gains On Diet Pill Nod From European Committee,2014-12-19 14:09:00-05:00,ARNA,positive
94533.0,Pharmaceutical Stocks In Play Following Merck/Cubist Deal,2014-12-08 09:09:00-05:00,ARNA,positive
94534.0,"8-K from Arena Pharma Shows Co., Eisai Discovered Some Bottles of BELVIQ Have Issue with Label, Eisai Voluntarily Initiated Recall from Wholesalers",2014-12-05 17:33:00-05:00,ARNA,neutral
94535.0,"Arena Pharma Reports Issued Composition of Matter Patent by US PTO for Ralinepag, Related Compounds",2014-11-25 08:02:00-05:00,ARNA,neutral
94536.0,"Option Alert: Arena Pharmaceuticals Apr $3 Call; 1,500 Contract Trade at Ask @$1.80; Currently $4.64",2014-11-14 09:38:00-05:00,ARNA,positive
94537.0,What's Driving Orexigen Therapeutics Higher?,2014-11-13 12:10:00-05:00,ARNA,neutral
94538.0,"Arena Pharmaceuticals Reports Q3 Loss, Shares Surge 6%",2014-11-03 08:37:00-05:00,ARNA,neutral
94539.0,Benzinga's Top #PreMarket Gainers,2014-11-03 08:09:00-05:00,ARNA,positive
94540.0,"Arena Pharma Reports Q3 EPS Loss $0.05, Revenues Of $8.16M Vs. Est. Of $11.0M",2014-11-03 06:48:00-05:00,ARNA,negative
94541.0,Arena Pharmaceuticals Says Lorcaserin Trial Met Primary Efficacy Endpoint; Demonstrated Statistically Significant Improvement Over Placebo ,2014-11-03 06:33:00-05:00,ARNA,positive
94542.0,"Earnings Scheduled For November 3, 2014",2014-11-03 05:18:00-05:00,ARNA,neutral
94543.0,3 Pharma Companies Fighting Obesity,2014-10-30 14:00:00-04:00,ARNA,negative
94544.0,Benzinga's Top #PreMarket Gainers,2014-10-29 08:12:00-04:00,ARNA,positive
94545.0,"Eisai, Arena Report Results of Investigational Pilot Study of Coadmin of Lorcaserin HCl, Phentermine HCl, Trial Met Primary Safety Objective After 12 Weeks",2014-10-28 18:22:00-04:00,ARNA,positive
94546.0,Bank Of America Q3 Small & Mid-Cap Biotech Preview,2014-10-20 16:58:00-04:00,ARNA,neutral
94547.0,"Option Alert: Arena Apr $3 Call 1,000 Contract Trade Above Ask @$1.29; Currently $3.92",2014-10-16 09:54:00-04:00,ARNA,positive
94548.0,UPDATE: Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at the American College of Clinical Pharmacy Annual Meeting,2014-10-13 08:39:00-04:00,ARNA,neutral
94549.0,Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at the American College of Clinical Pharmacy Annual Meeting ,2014-10-13 08:01:00-04:00,ARNA,neutral
94550.0,Eisai And Arena Pharmaceuticals Announce Publication Of Pooled Phase 3 Clinical Trial Analysis Of BELVIQ (lorcaserin HCl) CIV In Postgraduate Medicine,2014-10-10 11:37:00-04:00,ARNA,neutral
94551.0,Arena Pharma Shares Move Higher; May be Attributed to Adam F/Street.com Article ,2014-09-16 09:53:00-04:00,ARNA,positive
94552.0,Arena Pharm Has Received Orphan Drug Designation for PAH Treatment - Bloomberg,2014-08-29 11:02:00-04:00,ARNA,neutral
94553.0,Arena Pharmaceuticals Reports Q2 EPS of $0.03 Which May Not Compare $(0.11) Est; Revenue of $12.80M Which May Not Compare $9.81M Est,2014-08-01 05:43:00-04:00,ARNA,neutral
94554.0,"Earnings Scheduled For August 1, 2014",2014-08-01 05:23:00-04:00,ARNA,neutral
94555.0,Arena Pharma Announces BELVIQ Nominated For Prix Galien Award,2014-07-29 08:04:00-04:00,ARNA,positive
94556.0,"8-K from Arena Pharma Shows Will Receive Upfront, Milestone Payments for BELVIQ Supply Deal",2014-07-21 16:35:00-04:00,ARNA,neutral
94557.0,"Arena Announces Marketing, Supply Deal with Teva's Abic Marketing for BELVIQ in Israel ",2014-07-21 08:04:00-04:00,ARNA,neutral
94558.0,Benzinga's Top #PreMarket Losers,2014-07-11 08:19:00-04:00,ARNA,negative
94559.0,Arena Pharma Announces Eisai Closed Planned Boost in Sales Force for BELVIQ CIV,2014-07-10 08:01:00-04:00,ARNA,positive
94560.0,Markets Marginally Lower Ahead Of Earnings Season,2014-07-07 16:37:00-04:00,ARNA,negative
94561.0,Arena Pharmaceutical Shares Dive On News CEO Sold 40% Of His Shares,2014-07-07 12:45:00-04:00,ARNA,positive
94562.0,Arena Shares Trade Near Low; May be Attributed in Part to Adam F/Street.com Post,2014-07-07 11:28:00-04:00,ARNA,neutral
94563.0,Benzinga's Top #PreMarket Losers,2014-07-07 08:13:00-04:00,ARNA,negative
94564.0,Events Scheduled for Week of Jun. 16th to Jun. 20th,2014-06-17 10:48:00-04:00,ARNA,neutral
94565.0,Arena CEO Lief Says Marketing Partner Eisai has Not Discussed a Potential Acquisition of Arena,2014-06-11 17:34:00-04:00,ARNA,neutral
94566.0,Arena Pharmaceuticals CEO Jack Lief Appearing on CNBC; Says Prescriptions for Belviq Increasing,2014-06-11 17:31:00-04:00,ARNA,neutral
94567.0,Is Arena Pharmaceuticals A Biotech Stock To Watch? ,2014-06-11 14:15:00-04:00,ARNA,neutral
94568.0,Orexigen Shares Plummet Following FDA Decision; Competition Gets A Bump,2014-06-11 11:24:00-04:00,ARNA,positive
94569.0,Arena Pharmaceuticals Shares Spike Lower; May be Attributed to Seeking Alpha Article ,2014-06-06 13:19:00-04:00,ARNA,neutral
94570.0,Arena Pharma Reports Initiation of Phase 1b Trial of APD334,2014-06-03 08:07:00-04:00,ARNA,neutral
94571.0,Morning Market Movers ,2014-05-20 09:45:00-04:00,ARNA,neutral
94572.0,Arena Pharmaceuticals Shares Move Higher Premarket on Rumored Report of Potential Eisai Bid,2014-05-20 08:55:00-04:00,ARNA,positive
94573.0,"Arena Pharma Posts Q1 Loss Of $0.12/Share, Misses By ~$0.02/Share",2014-05-12 18:44:00-04:00,ARNA,negative
94574.0,"Arena Pharmaceuticals, Inc. Reports Q1 EPS of $(0.12) vs $(0.10) Est; Revenue of $6.80M vs $7.98M Est",2014-05-12 16:04:00-04:00,ARNA,neutral
94575.0,"Stocks To Watch For May 12, 2014",2014-05-12 07:36:00-04:00,ARNA,neutral
94576.0,"Earnings Scheduled For May 12, 2014",2014-05-12 06:18:00-04:00,ARNA,neutral
94577.0,"Earning and Economic Calendar for Monday May 12, 2014",2014-05-11 21:05:00-04:00,ARNA,neutral
94578.0,Arena Pharmaceuticals Reports Eisai Increase Sales Force for BELVIQ by 50%,2014-05-09 08:02:00-04:00,ARNA,positive
94579.0,"Stocks To Watch For May 06, 2014",2014-05-06 07:44:00-04:00,ARNA,neutral
94580.0,"Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE Moving Higher, ELGX, DECK, MDVN, CGEN, ARNA Lowr",2014-02-28 10:40:00-05:00,ARNA,neutral
94581.0,Benzinga's Top #PreMarket Losers,2014-02-28 08:15:00-05:00,ARNA,negative
94582.0,"Arena Pharmaceuticals, Inc. Reports Q4 EPS of $(0.11) vs $0.02 Est; Revenue of $6.52M, Up 236% YOY",2014-02-27 16:23:00-05:00,ARNA,neutral
94583.0,"Earnings Scheduled For February 27, 2014",2014-02-27 04:29:00-05:00,ARNA,neutral
94584.0,Bad Earnings Weigh In On Diet Stocks,2014-02-14 12:22:00-05:00,ARNA,negative
94585.0,Top Trending Tickers On StockTwits For February 14,2014-02-14 11:06:00-05:00,ARNA,positive
94586.0,"#PreMarket Primer: Friday, February 14: A Turnaround",2014-02-14 07:26:00-05:00,ARNA,neutral
94587.0,UPDATE: Arena Pharma Will Receive Milestone Payment of $500K on Filing,2014-02-12 08:07:00-05:00,ARNA,neutral
94588.0,Arena Pharmaceuticals Announces Filing for Marketing Authorization of BELVIQ® (lorcaserin HCl) in Brazil,2014-02-12 08:03:00-05:00,ARNA,neutral
94589.0,Market Wrap For February 10: Markets Cautious Ahead Of Yellen Testimony,2014-02-10 16:47:00-05:00,ARNA,negative
94590.0,Arena Pharmaceuticals Chairman Lief Sells 100K Shares- Form 4,2014-01-17 19:35:00-05:00,ARNA,positive
94591.0,Arena Shares Spike Lower,2014-01-17 15:36:00-05:00,ARNA,neutral
94592.0,"Option Alert: Arena Pharmaceuticals Jul $5 Call; 5,895 Contracts Traded Thursday vs 3,197 Open Interest; Currently $7.53",2014-01-16 11:29:00-05:00,ARNA,positive
94593.0,Arena Shares FRise 7.5%; May be Attributed to Seeking Alpha Article ,2013-12-26 10:23:00-05:00,ARNA,positive
94594.0,Benzinga's Top #PreMarket Gainers,2013-11-15 08:16:00-05:00,ARNA,positive
94595.0,"Wallachbeth Initiates Coverage on Arena Pharmaceuticals, Inc. at Buy, Announces $9.00 PT",2013-11-15 07:42:00-05:00,ARNA,neutral
94596.0,"Stocks to Watch for November 12, 2013",2013-11-12 11:50:00-05:00,ARNA,neutral
94597.0,Market Wrap For November 11: Relative Quiet as Traders and Investors Observe Holiday,2013-11-11 17:44:00-05:00,ARNA,positive
94598.0,Mid-Afternoon Market Update: Arena Pharma Gets a Boost on Jefferies Report as Markets Rise,2013-11-11 15:54:00-05:00,ARNA,positive
94599.0,Downside Protection For Arena Pharmaceuticals,2013-11-11 11:12:00-05:00,ARNA,negative
94600.0,"Jefferies Reiterates Buy Rating, $12 Price Target on Shares of Arena Pharma",2013-11-11 08:50:00-05:00,ARNA,positive
94601.0,Market Wrap For November 8: Markets Erase Thursday's Losses; Dow Companies Dominate Headlines,2013-11-08 16:57:00-05:00,ARNA,negative
94602.0,"Shares of Arena Pharma Resume Trade, Now Up ~4% from Close",2013-11-07 16:31:00-05:00,ARNA,positive
94603.0,"Arena Pharmaceuticals, Inc. Reports Q3 EPS of $(0.08) vs $(0.12) Est; Revenue of $3.60M vs $5.30M Est",2013-11-07 16:16:00-05:00,ARNA,neutral
94604.0,"Arena Pharma, Eisai Expand Marketing, Suppyl Deal for BELVIQ, Arena Eligible for Up to $176.5M in Milestone Payments",2013-11-07 16:05:00-05:00,ARNA,positive
94605.0,"Arena Pharmaceuticals, Eisai Expand Marketing and Supply Agreement for BELVIQ",2013-11-07 16:03:00-05:00,ARNA,positive
94606.0,Arena Pharma Halted Ahead of Earnings,2013-11-07 16:01:00-05:00,ARNA,neutral
94607.0,Benzinga's Top #PreMarket Losers,2013-11-01 08:13:00-04:00,ARNA,negative
94608.0,"Market Wrap For Tuesday, October 15: Earnings Reports And White House Progress Send Markets Down",2013-10-15 16:36:00-04:00,ARNA,positive
94609.0,Mid-Afternoon Market Update: Tumi Holdings Rises Amid Market Decline,2013-10-15 15:30:00-04:00,ARNA,neutral
94610.0,Mid-Morning Market Update: Markets Slip; Citigroup Profit Misses Estimates,2013-10-15 10:39:00-04:00,ARNA,positive
94611.0,UPDATE: Arena Says Eisai Will Double BELVIQ Sales Force to 400 Reps,2013-10-15 09:04:00-04:00,ARNA,neutral
94612.0,Arena Says Eisai Will Double BELVIQ Sales Force to 400 Reps,2013-10-15 09:03:00-04:00,ARNA,neutral
94613.0,"Vivus Weighs In As a Leader for Diet Pills, Cowen Upgrades and Raises PT",2013-10-03 16:42:00-04:00,ARNA,neutral
94614.0,"Cowen & Company Initiates Coverage on Arena Pharmaceuticals, Inc. at Market Perform, Announces $4.50 PT",2013-10-03 08:52:00-04:00,ARNA,neutral
94615.0,Benzinga's Top Pre-Market Losers,2013-10-01 08:43:00-04:00,ARNA,negative
94616.0,Piper Jaffray Cuts Target on Arena Pharma from $11.50 to $10,2013-10-01 08:10:00-04:00,ARNA,negative
94617.0,Market Wrap For September 30: Debt Ceiling And Government Shutdown Loom,2013-09-30 16:18:00-04:00,ARNA,negative
94618.0,Mid-Afternoon Market Update:  Mellanox Rallies As Market Remains in the Red,2013-09-30 15:37:00-04:00,ARNA,neutral
94619.0,Mid-Day Market Update: Dow Falls Over 100 Points; Active Network Shares Jump,2013-09-30 13:12:00-04:00,ARNA,positive
94620.0,Mid-Morning Market Update: Markets Open Lower; Cal-Maine Q1 Net Profit Declines 7%,2013-09-30 10:31:00-04:00,ARNA,positive
94621.0,"Arena Pharma Shares Down 5% Ahead of Open; Credit Suisse Lowered Price Target from $5 to $4, Maintains Underperform",2013-09-30 09:28:00-04:00,ARNA,positive
94622.0,UPDATE: Credit Suisse Lowers PT on Arena Pharmaceuticals Following Management Meeting,2013-09-30 09:26:00-04:00,ARNA,positive
94623.0,"Credit Suisse Maintains Underperform on Arena Pharmaceuticals, Inc., Lowers PT to $4.00",2013-09-30 07:19:00-04:00,ARNA,positive
94624.0,"Stocks to Watch for September 18, 2013",2013-09-18 09:27:00-04:00,ARNA,neutral
94625.0,"Arena Pharma Offers Update on Eisai Launch of BELVIQ, Says Placing Ads in US Magazines",2013-09-16 08:07:00-04:00,ARNA,neutral
94626.0,"Arena Pharma Exec Has Just Begun Presentation at BofA Merrill's Global Healthcare Conference, Says ~33K Belviq Scrips Filled as of Aug. 30th",2013-09-13 09:03:00-04:00,ARNA,neutral
94627.0,Stocks Hitting 52-Week Lows,2013-09-12 10:24:00-04:00,ARNA,negative
94628.0,"BMO Considers Recent Sales Data on Arena's Belviq, Maintains Market Perform Rating",2013-09-09 14:11:00-04:00,ARNA,neutral
94629.0,Stocks Hitting 52-Week Lows ,2013-08-30 10:10:00-04:00,ARNA,negative
94630.0,Stocks Hitting 52-Week Lows,2013-08-29 10:02:00-04:00,ARNA,negative
94631.0,Arena Pharma Reports Closing of Phase 1b Clinical Trial for APD811,2013-08-28 08:01:00-04:00,ARNA,neutral
94632.0,"Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, VRTX)",2013-08-27 13:29:00-04:00,ARNA,positive
94633.0,"Stocks to Watch for August 23, 2013",2013-08-23 10:42:00-04:00,ARNA,neutral
94634.0,"Arena Pharma Shares Moving Toward Session Lows as Piper's Tenthoff Cuts Target from $12.50 to $11.50, Maintains Overweight Rating",2013-08-01 12:10:00-04:00,ARNA,negative
94635.0,"Arena Pharmaceuticals, Inc. Reports Q2 EPS of $0.18 vs $0.14 Est",2013-08-01 07:31:00-04:00,ARNA,neutral
94636.0,"Weekly Preview: Earnings Season Continues, Fed In Focus, Economic Maelstrom Expected",2013-07-26 16:05:00-04:00,ARNA,neutral
94637.0,"Short Interest in Pharmacyclics Plunges (AMGN, ONXX, PCYC)",2013-07-26 10:46:00-04:00,ARNA,positive
94638.0,Arena Pharmaceuticals' BELVIQ® (lorcaserin HCl) CIV Nominated for 2013 Prix Galien USA Award ,2013-07-25 16:13:00-04:00,ARNA,positive
94639.0,Arena Pharmaceuticals and CY Biotech Enter into Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) in Taiwan ,2013-07-25 08:07:00-04:00,ARNA,positive
94640.0,"Short Interest Rises in Gilead Sciences, Onyx Pharmaceuticals (BIIB, GILD, ONXX)",2013-07-11 12:47:00-04:00,ARNA,positive
94641.0,Stocks Hitting 52-Week Lows,2013-07-05 10:57:00-04:00,ARNA,negative
94642.0,"Market Wrap for Friday, June 28: Major Averages Close Mixed; Dow Drops Triple Digits ",2013-06-28 16:42:00-04:00,ARNA,neutral
94643.0,"Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, VRTX)",2013-06-26 13:17:00-04:00,ARNA,positive
94644.0,"Arena Announces Belviq New Drug Submission in Canada, $500K Milestone Payment Triggered by Eisai App",2013-06-26 08:04:00-04:00,ARNA,neutral
94645.0,Arena Pharmaceuticals Announces BELVIQ™ (lorcaserin HCl) New Drug Submission in Canada ,2013-06-26 08:03:00-04:00,ARNA,neutral
94646.0,"Senators Carper, Murkowski, Representatives Cassidy, Kind Introduce Bill to Help Reduce Obesity",2013-06-19 12:47:00-04:00,ARNA,positive
94647.0,Hearing Chatter of Lawmakers Introducing Bill to Require Medicare to Cover Weight-Loss Drugs,2013-06-19 12:09:00-04:00,ARNA,neutral
94648.0,"Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB)",2013-06-12 13:29:00-04:00,ARNA,positive
94649.0,"Arena Pharma CEO Lief on CNBC, Calls Belviq 'Transformative'",2013-06-11 17:39:00-04:00,ARNA,neutral
94650.0,UPDATE: Piper Jaffray Raises PT on Arena Pharmaceuticals on Strong Belviq Survey,2013-06-11 14:06:00-04:00,ARNA,positive
94651.0,"Piper Jaffray Maintains Overweight on Arena Pharmaceuticals, Inc., Raises PT to $12.50",2013-06-11 10:41:00-04:00,ARNA,negative
94652.0,Arena Pharmaceuticals Reports on Launch of BELVIQ (lorcaserin HCl) CIV for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese; Reaches $65M Milestone,2013-06-07 08:06:00-04:00,ARNA,negative
94653.0,"Short Interest in Vertex Rises, in Biogen Idec Falls",2013-05-29 13:19:00-04:00,ARNA,positive
94654.0,"Stocks to Watch for May 29, 2013",2013-05-29 09:36:00-04:00,ARNA,neutral
94655.0,"Market Wrap for Tuesday, May 28: Bull Run Continues as Economic Data Sparks Another Rally",2013-05-28 16:36:00-04:00,ARNA,neutral
94656.0,"Short Interest in Vertex Rises, in Celgene Falls",2013-05-11 10:45:00-04:00,ARNA,positive
94657.0,UPDATE: Arena Says BELVIQ to be Placed in Federal Register Tomorrow,2013-05-07 15:34:00-04:00,ARNA,neutral
94658.0,"UPDATE: Arena Pharma Issues Update on Upcoming US Launch of BELVIQ, to Get $65M Milestone Payment from Eisai",2013-05-07 15:33:00-04:00,ARNA,neutral
94659.0,"Arena Pharma Issues Update on Upcoming US Launch of BELVIQ, to Get $65M Milestone Payment from Eisai",2013-05-07 15:31:00-04:00,ARNA,neutral
94660.0,Arena Shares Rise After Release of DEA Report on Lorcaserin ,2013-05-07 09:05:00-04:00,ARNA,positive
94661.0,"Market Wrap for Friday, May 3: Stocks Jump on Strong Jobs Data",2013-05-03 16:28:00-04:00,ARNA,positive
94662.0,"Mid-Afternoon Market Update: Dow Eyeing Record Close, American Axle Rises",2013-05-03 15:52:00-04:00,ARNA,neutral
94663.0,"Mid-Day Market Update: Thoratec Dips On Downbeat Profit, InvenSense Rises",2013-05-03 13:03:00-04:00,ARNA,positive
94664.0,"Mid-Morning Market Update: Markets Surge On Jobs Data, Dow Breaks 15,000 for the First Time in History",2013-05-03 10:32:00-04:00,ARNA,neutral
94665.0,"Arena Pharmaceuticals, Inc. Reports Q1 EPS of $(0.09) vs $0.11 Est",2013-05-02 16:03:00-04:00,ARNA,neutral
94666.0,Weekly Preview: Focus Shifts from Earnings to Economy,2013-04-26 16:35:00-04:00,ARNA,neutral
94667.0,"Short Sellers Move into Celgene, Regeneron",2013-04-26 13:25:00-04:00,ARNA,neutral
94668.0,"Stocks to Watch for April 18, 2013",2013-04-18 08:36:00-04:00,ARNA,neutral
94669.0,"Vivus, Arena Spike Higher",2013-04-16 14:31:00-04:00,ARNA,neutral
94670.0,"Short Sellers Move Out of Amgen, Celgene, Pharmacyclics",2013-04-10 13:30:00-04:00,ARNA,neutral
94671.0,Arena Pharma Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases,2013-04-05 08:02:00-04:00,ARNA,neutral
94672.0,Form 8-K Shows Arena Has Said California Granted Motion to Dismiss Holder Actions,2013-04-01 16:51:00-04:00,ARNA,positive
94673.0,Arena Pharmaceuticals Announces Eisai's Submission of BELVIQ Marketing Authorization Application in Mexico,2013-04-01 08:01:00-04:00,ARNA,neutral
94674.0,"Short Sellers Dump Amgen, Focus on Celgene, Gilead Sciences",2013-03-28 08:18:00-04:00,ARNA,negative
94675.0,Tuesday March 26th Watchlist,2013-03-26 08:18:00-04:00,ARNA,neutral
94676.0,"Short Interest Swings in Biotech Stocks (AMGN, CELG, PCYC)",2013-03-12 13:19:00-04:00,ARNA,positive
94677.0,UPDATE: JP Morgan Cuts PT to $7 on Arena Pharmaceuticals on Belviq Launch Concerns,2013-03-05 15:05:00-05:00,ARNA,positive
94678.0,"BMO Capital Maintains Market Perform on Arena Pharmaceuticals, Inc., Lowers PT to $8.00",2013-03-05 09:04:00-05:00,ARNA,negative
94679.0,"JP Morgan Maintains Neutral on Arena Pharmaceuticals, Inc., Lowers PT to $7.00",2013-03-05 08:45:00-05:00,ARNA,positive
94680.0,"Arena Pharmaceuticals, Inc. Reports Q4 GAAP EPS of $(0.10) vs $(0.03) Est; Revenue of $1.90M, Down 9% YOY",2013-03-04 07:19:00-05:00,ARNA,neutral
94681.0,"Benzinga Market Primer: Monday, March 4",2013-03-04 06:15:00-05:00,ARNA,neutral
94682.0,US Stock Futures Down; Gold Rises ,2013-03-04 06:00:00-05:00,ARNA,neutral
94683.0,"Earnings Scheduled For March 4, 2013",2013-03-04 04:11:00-05:00,ARNA,neutral
94684.0,"Stocks To Watch For March 4, 2013",2013-03-04 04:02:00-05:00,ARNA,neutral
94685.0,"Short Interest Swings in Biotech Stocks (ALXN, AMGN, CELG)",2013-02-28 15:13:00-05:00,ARNA,positive
94686.0,From 8-K from Arena Pharma Showing Eisai Disclosed Wholesale Cost for Belviq $199.50/Bottle 60 10mg Pills,2013-02-25 09:53:00-05:00,ARNA,neutral
94687.0,"Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)",2013-02-12 13:29:00-05:00,ARNA,positive
94688.0,"Leerink Swann Resumed Outperform on Arena Pharmaceuticals, Inc.",2013-02-06 10:07:00-05:00,ARNA,neutral
94689.0,"Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)",2013-01-26 12:17:00-05:00,ARNA,positive
94690.0,Pharmas Look to Fatten Up With Obesity Drugs,2013-01-24 13:25:00-05:00,ARNA,neutral
94691.0,"Mid-Afternoon Market Update: Markets All Green, Research in Motion Looks to Test High 17's",2013-01-22 16:09:00-05:00,ARNA,neutral
94692.0,"Mid-Day Market Update: GenCorp Rises, Markets Erasing Losses ",2013-01-22 14:08:00-05:00,ARNA,negative
94693.0,"Mid-Morning Market Update: Verizon Misses Big on Earnings, Research in Motion Skyrockets",2013-01-22 10:45:00-05:00,ARNA,negative
94694.0,UPDATE: Arena Says Received 'Day 180' List of Outstanding Issues from EMA's CHMP,2013-01-22 08:43:00-05:00,ARNA,positive
94695.0,"Arena Pharma Receives Day 180 List for Belviq, Says CHMP's Estimate Final Opinion for MAA by Day 210",2013-01-22 08:04:00-05:00,ARNA,neutral
94696.0,Trading The News,2013-01-18 12:02:00-05:00,ARNA,neutral
94697.0,Wednesday January 16th watchlist,2013-01-16 17:02:00-05:00,ARNA,neutral
94698.0,"Mid-Afternoon Market Update: Markets Mixed, Given Drops After Company Abandons Sale",2013-01-15 15:34:00-05:00,ARNA,negative
94699.0,Wednesday January 9th Watchlist,2013-01-09 11:49:00-05:00,ARNA,neutral
94700.0,"Mid-Morning Market Update: Markets Rising, Herbalife Boosts on Dan Loeb Stake",2013-01-09 10:21:00-05:00,ARNA,positive
94701.0,"Arena Pharma CEO Lief Says Seeking Commercial Partners in Europe, Asia - Bloomberg",2013-01-07 15:41:00-05:00,ARNA,neutral
94702.0,The Best Small Cap Performers of 2012,2012-12-30 11:07:00-05:00,ARNA,positive
94703.0,"Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)",2012-12-28 11:10:00-05:00,ARNA,positive
94704.0,Arena Pharmaceuticals 3% Higher Pre-Market; May be Attributed to Seeking Alpha Blog Post,2012-12-28 09:10:00-05:00,ARNA,neutral
94705.0,Benzinga's Top Pre-Market Gainers,2012-12-28 08:14:00-05:00,ARNA,positive
94706.0,Arena Pharmaceuticals Spiking Lower,2012-12-19 15:18:00-05:00,ARNA,negative
94707.0,DEA Proposes Schedule IV Status for Arena's Lorcaserin,2012-12-18 09:29:00-05:00,ARNA,neutral
94708.0,Arena Pharmaceuticals Spiking Higher Pre-Market,2012-12-18 09:25:00-05:00,ARNA,neutral
94709.0,6 stocks to watch in the week ahead,2012-12-17 11:54:00-05:00,ARNA,neutral
94710.0,"Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)",2012-12-12 12:57:00-05:00,ARNA,positive
94711.0,"Arena Pharmaceuticals, Ildong Pharmaceutical Announce License Agreement",2012-11-28 06:16:00-05:00,ARNA,positive
94712.0,Acadia Pharma Rockets Higher on Study Results,2012-11-27 16:44:00-05:00,ARNA,neutral
94713.0,"Stocks To Watch For November 14, 2012",2012-11-14 11:10:00-05:00,ARNA,neutral
94714.0,"Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)",2012-11-12 13:24:00-05:00,ARNA,positive
94715.0,"UPDATE: Jefferies & Company Reiterates Buy Rating, Lowers PT on Arena Pharmaceuticals",2012-11-07 10:11:00-05:00,ARNA,negative
94716.0,VIVUS Shares Hit Hard After Earnings,2012-11-07 08:30:00-05:00,ARNA,positive
94717.0,"Jefferies & Company Maintains Arena Pharmaceuticals at Buy, Lowers PT from $20 to $14",2012-11-07 07:05:00-05:00,ARNA,negative
94718.0,Arena Pharmaceuticals Reports Q3 EPS $-0.07 vs $-0.09 Est; Revenues $1.5M vs $3.51M Est,2012-11-06 16:26:00-05:00,ARNA,neutral
94719.0,Arena to Sell Belviq to Ildong at 35% Ildong Year Net Sales,2012-11-06 16:05:00-05:00,ARNA,neutral
94720.0,"Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)",2012-10-25 14:09:00-04:00,ARNA,positive
94721.0,"Stocks Watchlist For Thursday, October 18",2012-10-18 09:31:00-04:00,ARNA,neutral
94722.0,Arena Pharmaceuticals Spokesperson Says Wednesday's Strength May be Attributed to Feature in 'The Doctors' TV Show on Tuesday,2012-10-17 12:52:00-04:00,ARNA,positive
94723.0,Arena Pharmaceuticals Spiking Higher,2012-10-17 09:42:00-04:00,ARNA,neutral
94724.0,"Short Interest Swings in Biotech Stocks (BIIB, CELG, GILD)",2012-10-15 06:59:00-04:00,ARNA,positive
94725.0,Arena Pharmaceuticals Spikes to Highs,2012-10-12 10:37:00-04:00,ARNA,neutral
94726.0,"Stocks to watch on Friday, October 12",2012-10-12 09:22:00-04:00,ARNA,neutral
94727.0,Arena Pharmaceuticals Initiates Phase 1 Multiple Dose Clinical Trial of APD811 for Pulmonary Arterial Hypertension,2012-10-12 08:05:00-04:00,ARNA,neutral
94728.0,Arena Pharmaceuticals and VIVUS Weight Loss Drugs Approved by FDA,2012-10-02 08:30:00-04:00,ARNA,positive
94729.0,Long set-ups for Wednesday,2012-09-19 10:23:00-04:00,ARNA,neutral
94730.0,Short Sellers Shy Away from Biotech Firms,2012-09-13 13:34:00-04:00,ARNA,negative
94731.0,Benzinga's Top Pre-Market Gainers,2012-09-13 08:12:00-04:00,ARNA,positive
94732.0,Arena Pharmaceuticals Spikes to Lows,2012-09-10 15:32:00-04:00,ARNA,negative
94733.0,"UPDATE: Arena Pharma Says Balance Sheet is Strong, Has Prepaid All Outstanding Debts",2012-09-07 11:02:00-04:00,ARNA,positive
94734.0,Arena Says It Sees Approval for Belviq in Europe in First Half of 2013,2012-09-07 10:57:00-04:00,ARNA,positive
94735.0,Arena Pharma Starts Presentation at Biotech Conference,2012-09-07 10:32:00-04:00,ARNA,neutral
94736.0,UPDATE: Credit Suisse Initiates Arena Pharmaceuticals at Underperform on Belviq Expectations  ,2012-09-06 07:22:00-04:00,ARNA,positive
94737.0,Credit Suisse Initiates Coverage on Arena Pharmaceuticals at Underperform,2012-09-06 06:14:00-04:00,ARNA,positive
94738.0,Short Interest in Biotech Firms on the Rise,2012-08-27 15:21:00-04:00,ARNA,positive
94739.0,Arena Pharmaceuticals Spokesperson Says No Specific News to Account for Wednesday's Move,2012-08-22 14:43:00-04:00,ARNA,negative
94740.0,Arena Pharmaceuticals Rises 5% Pre-Market,2012-08-15 08:12:00-04:00,ARNA,neutral
94741.0,"Benzinga'a M&A Chatter for Tuesday August 14, 2012",2012-08-14 17:23:00-04:00,ARNA,neutral
94742.0,Arena Pharmaceuticals Spikes Higher After-Hours,2012-08-14 16:31:00-04:00,ARNA,neutral
94743.0,Arena Pharmaceuticals Rises 15% on Takeover Speculation,2012-08-14 15:32:00-04:00,ARNA,neutral
94744.0,GlaxoSmithKline Spokesperson Declines Comment on Arena Pharmaceuticals Takeover Chatter,2012-08-14 14:29:00-04:00,ARNA,neutral
94745.0,Hearing Unconfirmed Takeover Chatter in Arena Pharmaceuticals,2012-08-14 14:02:00-04:00,ARNA,negative
94746.0,Arena Pharmaceuticals Reports Q2 EPS $-0.12 May Not Compare to $-0.07 Est; Revenues $22M May Not Compare to $10.04M Est,2012-08-09 16:29:00-04:00,ARNA,neutral
94747.0,Wednesday Market Movers ,2012-07-18 12:31:00-04:00,ARNA,neutral
94748.0,"JP Morgan Maintains Arena Pharmaceuticals at Neutral, Raises PT from $11 to $9",2012-07-18 06:52:00-04:00,ARNA,positive
94749.0,"Arena Pharmaceuticals Spiking Lower on Vivus Qnexa Approval, Orexigen Spiking Higher",2012-07-17 19:18:00-04:00,ARNA,positive
94750.0,Benzinga's Top Pre-Market Losers,2012-07-17 08:21:00-04:00,ARNA,negative
94751.0,Arena Pharmaceuticals Spiking Lower,2012-07-12 10:34:00-04:00,ARNA,negative
94752.0,Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control,2012-07-11 16:05:00-04:00,ARNA,neutral
94753.0,Arena Pharmaceuticals Falls 6% Pre-Market; Jim Cramer Said Arena was a 'Sell' on Mad Money on Tuesday,2012-07-11 08:24:00-04:00,ARNA,negative
94754.0,Arena Pharmaceuticals Falls 5% After-Hours on Negative Comments by Jim Cramer on Mad Money,2012-07-10 18:44:00-04:00,ARNA,negative
94755.0,Arena Pharmaceuticals Receives Cautious Mad Money/Jim Cramer Mention -CNBC ,2012-07-10 18:31:00-04:00,ARNA,negative
94756.0,Arena Pharmaceuticals Voted Best Potential Performer by Mad Money Viewers,2012-07-10 18:30:00-04:00,ARNA,positive
94757.0,"Dendreon, Pharmacyclics and Other Biotech Takeover Targets",2012-07-10 14:07:00-04:00,ARNA,neutral
94758.0,Arena Pharmaceuticals Spikes Higher on Heavy Volume,2012-07-10 10:02:00-04:00,ARNA,neutral
94759.0,Benzinga's Top Pre-Market Gainers,2012-07-10 08:12:00-04:00,ARNA,positive
94760.0,"Option Alert: Heavy Volume in Arena Pharmaceuticals July 12 Call, 1,338 Contracts Traded; Currently $11.77",2012-07-06 09:37:00-04:00,ARNA,positive
94761.0,"Arena Pharmaceuticals Spikes Higher at Open, Vivus Spikes Lower",2012-07-06 09:31:00-04:00,ARNA,negative
94763.0,"From Earlier: Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs",2012-07-05 14:31:00-04:00,ARNA,positive
94764.0,These Are Four of the Hottest Biotechs in the Market Right Now,2012-07-05 13:19:00-04:00,ARNA,neutral
94765.0,Strength in Arena Pharmaceuticals May be Attributed to Positive Seeking Alpha Article,2012-07-05 10:18:00-04:00,ARNA,positive
94766.0,Stock setups to watch next week,2012-06-29 17:56:00-04:00,ARNA,neutral
94767.0,Orexigen Therapeutics Rallying After Arena Pharmaceuticals' FDA Approval ,2012-06-28 15:09:00-04:00,ARNA,positive
94768.0,JP Morgan Upgrades Orexigen Therapeutics to Overweight,2012-06-28 14:23:00-04:00,ARNA,neutral
94769.0,UPDATE: Bank of America Raises PO to $7 on Arena Pharmaceuticals on Lorcaserin Aproval  ,2012-06-28 12:29:00-04:00,ARNA,negative
94770.0,UPDATE: Jefferies Raises PT to $20 on Arena Pharmaceuticals on Belviq FDA Aproval  ,2012-06-28 12:29:00-04:00,ARNA,neutral
94771.0,Weight Watchers Spiking,2012-06-28 11:53:00-04:00,ARNA,neutral
94772.0,"Social Media Outlook for Thursday June 28 (ENOC, ENTR, JPM, VRTX)",2012-06-28 10:17:00-04:00,ARNA,neutral
94773.0,Ultimate Stock Watch List for The Supreme Court's Health Care Ruling,2012-06-28 09:51:00-04:00,ARNA,positive
94774.0,"Jefferies & Company Maintains Arena Pharmaceuticals at Buy, Raises PT from $9 to $20",2012-06-28 06:50:00-04:00,ARNA,neutral
94775.0,"Bank of America Maintains Arena Pharmaceuticals at Underperform, Raises PO from $5 to $7",2012-06-28 06:48:00-04:00,ARNA,negative
94776.0,"JP Morgan Maintains Arena Pharmaceuticals at Neutral, Raises PT from $8 to $11",2012-06-28 05:58:00-04:00,ARNA,positive
94777.0,Arena Pharmaceuticals CEO Says Belviq Will be Moderately Priced,2012-06-27 16:26:00-04:00,ARNA,neutral
94778.0,FDA Approves Arena's Lorcaserin,2012-06-27 14:55:00-04:00,ARNA,positive
94779.0,"Arena Approval Boosts Biotech ETFs (ARNA, IBB, XBI)",2012-06-27 14:41:00-04:00,ARNA,positive
94780.0,Arena Pharmaceuticals Conference Call Ends,2012-06-27 14:41:00-04:00,ARNA,neutral
94781.0,Arena Pharmaceuticals Falls Below $11/Share,2012-06-27 14:33:00-04:00,ARNA,neutral
94782.0,"Arena Says if Patients Aren't Losing 5% in the 12 Week Treatment, There is No Reason to Continue",2012-06-27 14:31:00-04:00,ARNA,neutral
94783.0,Arena Says Belviq Has Not Been Studied for Use with Other Weight-Loss Agents,2012-06-27 14:23:00-04:00,ARNA,neutral
94784.0,Arena Says Working on Approval for Belviq in Other Parts of the World,2012-06-27 14:20:00-04:00,ARNA,positive
94785.0,"Piper Jaffray Maintains Arena Pharmaceuticals at Overweight, Raises PT from $7 to $11",2012-06-27 14:19:00-04:00,ARNA,negative
94786.0,Arena Says Have No Plans to Raise Additional Money At This Time,2012-06-27 14:18:00-04:00,ARNA,negative
94787.0,Arena Says DEA Sets Belviq as Schedule 4 Drug,2012-06-27 14:16:00-04:00,ARNA,neutral
94788.0,Arena Says Will Not Discuss Belviq Pricing in Conference Call,2012-06-27 14:13:00-04:00,ARNA,neutral
94789.0,Arena Says Company Has Patents Through 2023,2012-06-27 14:11:00-04:00,ARNA,neutral
94790.0,Arena Says Primary Goal for Belviq (Lorcaserin) Was US FDA Approval,2012-06-27 14:11:00-04:00,ARNA,positive
94791.0,Arena Pharmaceuticals Conference Call Begins,2012-06-27 14:07:00-04:00,ARNA,neutral
94792.0,Arena Pharmaceuticals Resumes Trading at $13.50,2012-06-27 13:45:00-04:00,ARNA,neutral
94793.0,Arena Pharmaceuticals Resumes Trading ,2012-06-27 13:45:00-04:00,ARNA,neutral
94794.0,Arena Pharmaceuticals Conference Call at 2:00pm,2012-06-27 13:24:00-04:00,ARNA,neutral
94795.0,PREVIEW: Arena Pharmaceuticals to Resume Trading at 1:45 pm,2012-06-27 13:23:00-04:00,ARNA,neutral
94796.0,Arena Pharmaceuticals to Resume at 1:45pm,2012-06-27 13:23:00-04:00,ARNA,neutral
94797.0,Orexigen Therapeutics Hits 52-Week Highs on Arena Approval,2012-06-27 13:17:00-04:00,ARNA,positive
94798.0,Arena Pharmaceuticals and Eisai Announce FDA Approval of BELVIQ,2012-06-27 13:14:00-04:00,ARNA,positive
94799.0,Orexigen Therapeutics Crosses $5/Share on FDA Approval,2012-06-27 13:09:00-04:00,ARNA,positive
94800.0,"Vivus, Orexigen Spike Higher on Arena Approval",2012-06-27 12:53:00-04:00,ARNA,positive
94801.0,Arena's Weight-Loss Drug Approved,2012-06-27 12:51:00-04:00,ARNA,positive
94802.0,Arena Pharmaceuticals Lorcaserin Approved by FDA,2012-06-27 12:51:00-04:00,ARNA,positive
94803.0,Arena Pharma Halted for News,2012-06-27 12:40:00-04:00,ARNA,neutral
94804.0,"Social Media Outlook for Wednesday June 27 (MKC, LEN, ORLY, BA)",2012-06-27 11:13:00-04:00,ARNA,neutral
94805.0,NASDAQ Spokesperson Not Commenting on Possible Arena Pharmaceuticals Trade Halt Ahead of FDA Decision,2012-06-27 10:30:00-04:00,ARNA,neutral
94806.0,Arena Pharmaceuticals Spiking Higher Pre-Market Ahead of FDA Decision,2012-06-27 09:00:00-04:00,ARNA,neutral
94807.0,Benzinga's Top Pre-Market Losers,2012-06-27 08:26:00-04:00,ARNA,negative
94808.0,"Social Media Outlook for Tuesday June 26 (APOL, SBAC, GEOY, HE)",2012-06-26 11:13:00-04:00,ARNA,neutral
94809.0,Arena Pharmaceuticals Spiking Lower,2012-06-26 10:13:00-04:00,ARNA,negative
94810.0,Benzinga's Top Pre-Market Gainers,2012-06-26 08:17:00-04:00,ARNA,positive
94811.0,"Benzinga's Downgrade Summary for June 25, 2012",2012-06-25 15:29:00-04:00,ARNA,neutral
94812.0,"Arena Pharmaceuticals Reverses Rally, Trading Lower",2012-06-25 14:13:00-04:00,ARNA,negative
94813.0,Adam F Says Arena's Lorcaserin FDA Panel Minutes Don't Appear to be Positive for Approval Without Restrictions,2012-06-25 13:11:00-04:00,ARNA,positive
94814.0,FDA Arena Pharmaceuticals Panel Minutes Posted,2012-06-25 13:05:00-04:00,ARNA,neutral
94815.0,"UPDATE: BMO Capital Markets Downgrades Arena Pharmaceuticals to Market Perform, Reiterates $10 PT",2012-06-25 12:08:00-04:00,ARNA,neutral
94816.0,"Social Media Outlook for Monday June 25 (TEVA, MNTA, BMY, XOM)",2012-06-25 11:25:00-04:00,ARNA,neutral
94817.0,Arena Pharmaceuticals Rises 4.5% Ahead of Wednesday's PDUFA,2012-06-25 09:45:00-04:00,ARNA,neutral
94818.0,Arena Pharmaceuticals Spiking Higher,2012-06-25 09:38:00-04:00,ARNA,neutral
94819.0,Arena Pharmaceuticals Falls 9% Pre-Market Ahead of Lorcaserin PDUFA on Wednesday,2012-06-25 08:25:00-04:00,ARNA,neutral
94820.0,"BMO Capital Markets Downgrades Arena Pharmaceuticals from Outperform to Market Perform, Maintains PT at $10",2012-06-25 08:05:00-04:00,ARNA,neutral
94821.0,"Social Media Outlook for Friday June 22 (DRI, NPSP, R, GS)",2012-06-22 12:18:00-04:00,ARNA,neutral
94822.0,Mid-Day Market Losers,2012-06-22 12:06:00-04:00,ARNA,negative
94823.0,Did a Bear Raid Cause the Sell-Off in Arena Pharmaceuticals?,2012-06-22 11:56:00-04:00,ARNA,neutral
94824.0,Arena Pharmaceuticals Spokesperson Has No Comment on Share Price Activity,2012-06-22 10:14:00-04:00,ARNA,neutral
94825.0,Arena Pharmaceuticals Plunges Then Recovers,2012-06-22 09:58:00-04:00,ARNA,neutral
94826.0,Arena Pharmaceuticals Shares Rally Back Over $11 Following Earlier 'Bear Raid',2012-06-22 09:52:00-04:00,ARNA,positive
94827.0,Arena Pharmaceuticals Spikes Lower; May be Attributed to Cautious Seeking Alpha Article,2012-06-22 09:40:00-04:00,ARNA,negative
94828.0,Arena Pharmaceuticals Spiking Lower,2012-06-22 09:35:00-04:00,ARNA,negative
94829.0,Benzinga's Top Pre-Market Gainers,2012-06-22 08:18:00-04:00,ARNA,positive
94830.0,Arena Pharmaceuticals Crosses $12/Share Pre-Market,2012-06-22 07:09:00-04:00,ARNA,neutral
94831.0,Trade setups to keep on your trading watch list,2012-06-21 18:15:00-04:00,ARNA,neutral
94832.0,Arena Pharmaceuticals Spiking Higher,2012-06-21 09:41:00-04:00,ARNA,neutral
94833.0,Stock Trade Ideas for Thursday June 21,2012-06-20 17:44:00-04:00,ARNA,neutral
94834.0,Arena Pharmaceuticals Spiking Higher on Positive Jim Cramer/Mad Money Comments on Tuesday,2012-06-20 09:50:00-04:00,ARNA,positive
94835.0,Benzinga's Top Pre-Market Gainers,2012-06-20 08:22:00-04:00,ARNA,positive
94836.0,Arena Pharmaceuticals Receives Positive Mad Money/Jim Cramer Mention -CNBC,2012-06-19 18:12:00-04:00,ARNA,positive
94837.0,Stock Trade Ideas for Wednesday June 20,2012-06-19 17:24:00-04:00,ARNA,neutral
94838.0,Arena Pharmaceuticals Spiking Lower,2012-06-19 14:07:00-04:00,ARNA,negative
94839.0,Arena Pharmaceuticals Trading 7.2% Higher on Heavy Volume; Currently at $10.06,2012-06-19 11:02:00-04:00,ARNA,neutral
94840.0,Arena Pharmaceuticals Hits $10/Share,2012-06-19 09:34:00-04:00,ARNA,neutral
94841.0,Benzinga's Top Pre-Market Gainers,2012-06-19 08:06:00-04:00,ARNA,positive
94842.0,Stocks Hitting 52-Week Highs,2012-06-18 10:11:00-04:00,ARNA,neutral
94843.0,Benzinga's Top Pre-Market Gainers,2012-06-18 08:10:00-04:00,ARNA,positive
94844.0,"Few trade ideas for tomorrow, June 14th",2012-06-13 17:23:00-04:00,ARNA,neutral
94845.0,Piper Jaffray Maintains Overweight on Arena Pharmaceuticals on Share Rally,2012-06-13 11:45:00-04:00,ARNA,negative
94846.0,Arena Pharmaceuticals Spiking Lower,2012-06-13 11:14:00-04:00,ARNA,negative
94847.0,Arena Pharmaceuticals Trading 7.4% Higher on Heavy Volume; Currently at $8.46,2012-06-13 09:47:00-04:00,ARNA,neutral
94848.0,"Stock Trade Ideas for Wednesday, June 13th",2012-06-12 17:16:00-04:00,ARNA,neutral
94849.0,"Social Media Outlook for Tuesday June 12 (ARNA, VLO, GRMN, TXN)",2012-06-12 13:34:00-04:00,ARNA,neutral
94850.0,Arena Pharmaceuticals Trading 4.1% Higher on Heavy Volume; Currently at $7.36,2012-06-12 09:35:00-04:00,ARNA,neutral
94851.0,Benzinga's Top Pre-Market Gainers,2012-06-12 08:06:00-04:00,ARNA,positive
94852.0,"Stock Trade Ideas for Tuesday, June 12th",2012-06-11 17:17:00-04:00,ARNA,neutral
94853.0,Arena Pharmaceuticals Trading 6% Higher on Heavy Volume; Currently at $7.02,2012-06-11 10:14:00-04:00,ARNA,neutral
94854.0,Arena Pharmaceuticals Spiking Higher on Heavy Volume; Currently at $6.89,2012-06-11 10:02:00-04:00,ARNA,neutral
94855.0,Ten Analyst Calls That Made You 60-Plus Percent in 2012,2012-06-07 14:01:00-04:00,ARNA,neutral
94856.0,Vivus' Qnexa Is Not Guaranteed Approval. Remember Provenge?,2012-05-31 12:52:00-04:00,ARNA,negative
94857.0,Arena Pharmaceuticals Spiking Higher,2012-05-30 09:49:00-04:00,ARNA,neutral
94858.0,Benzinga's Top Pre-Market Gainers ,2012-05-29 08:10:00-04:00,ARNA,positive
94859.0,4 Smaller Alternatives to Big Pharma Obesity Treatments,2012-05-25 13:17:00-04:00,ARNA,neutral
94860.0,Arena Pharmaceuticals Trading 6.6% Higher on Heavy Volume; Currently at $6.31,2012-05-22 09:56:00-04:00,ARNA,neutral
94861.0,Benzinga's Top Pre-Market Gainers,2012-05-22 08:06:00-04:00,ARNA,positive
94862.0,The Strongest Small-Caps in the Market,2012-05-21 16:04:00-04:00,ARNA,positive
94863.0,Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock ,2012-05-21 16:01:00-04:00,ARNA,neutral
94864.0,Benzinga's Top Pre-Market Losers,2012-05-18 08:10:00-04:00,ARNA,negative
94865.0,Arena Pharmaceuticals Prices Public Offering of 11M Shares at $5.50 Share ,2012-05-16 08:50:00-04:00,ARNA,positive
94866.0,Arena Pharmaceuticals Falls 9% Pre-Market on Secondary Announcement,2012-05-16 07:11:00-04:00,ARNA,neutral
94867.0,Arena Pharma Files Automatic Mixed Securities Shelf,2012-05-15 16:34:00-04:00,ARNA,positive
94868.0,Arena Pharmaceuticals Falls 2.70% on Secondary Announcement,2012-05-15 16:03:00-04:00,ARNA,neutral
94869.0,Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock ,2012-05-15 16:02:00-04:00,ARNA,neutral
94870.0,Arena Pharmaceuticals Rises 6% Pre-Market ,2012-05-14 08:10:00-04:00,ARNA,neutral
94871.0,US Stock Futures Signal Lower Start On Wall Street,2012-05-14 06:21:00-04:00,ARNA,negative
94872.0,Stocks To Watch For May 14,2012-05-14 02:17:00-04:00,ARNA,neutral
94873.0,"Oppenheimer Maintains Perform Rating, Does Not Set PT for Arena Pharmaceuticals",2012-05-11 17:29:00-04:00,ARNA,neutral
94874.0,Hot Stocks to Keep on Your Radar Screen Next week,2012-05-11 17:26:00-04:00,ARNA,neutral
94875.0,Orexigen Therapeutics Sitting At Session Highs,2012-05-11 14:08:00-04:00,ARNA,neutral
94876.0,"Benzinga's Top Upgrades with Color for May 11, 2012",2012-05-11 12:58:00-04:00,ARNA,positive
94877.0,"Arena, Vivus, Orexigen are All Takeover Targets -Optionmonster",2012-05-11 12:39:00-04:00,ARNA,neutral
94878.0,"Piper Jaffray Upgrades Arena Pharmaceuticals from Neutral to Overweight, Raises PT from $2.5 to $7",2012-05-11 12:15:00-04:00,ARNA,negative
94879.0,"Option Alert: Arena Pharmaceuticals July 7/October 7 Call Spread, Block Trade, 9,700 Contracts, Currently $5.76",2012-05-11 11:54:00-04:00,ARNA,negative
94880.0,Arena Pharmaceuticals up 63% on Positive FDA Panel Vote ,2012-05-11 10:59:00-04:00,ARNA,positive
94881.0,"Social Media Outlook for Friday May 11 (NVDA, INSP, JPM, CSCO)",2012-05-11 10:35:00-04:00,ARNA,neutral
94882.0,UPDATE: Jefferies Upgrades Arena Pharmaceuticals; Raises PT,2012-05-11 07:59:00-04:00,ARNA,neutral
94883.0,"Financial Breakfast: Morning News Summary for May 11, 2012",2012-05-11 07:20:00-04:00,ARNA,neutral
94884.0,Arena Pharmaceuticals Rises 98% Pre-Market on FDA Panel Vote for Approval of Lorcaserin,2012-05-11 07:10:00-04:00,ARNA,positive
94885.0,"Jefferies & Company Upgrades Arena Pharmaceuticals from Underperform to Buy, Raises PT from $1 to $9",2012-05-11 06:47:00-04:00,ARNA,neutral
94886.0,Arena Pharmaceuticals Resumes Trading Up 200%,2012-05-10 17:51:00-04:00,ARNA,neutral
94887.0,Arena Pharmaceuticals Resumes Trading,2012-05-10 17:50:00-04:00,ARNA,neutral
94888.0,PREVIEW: Arena Pharmaceuticals to Resume Trading at 5:50pm,2012-05-10 17:34:00-04:00,ARNA,neutral
94889.0,Arena and Eisai Expand Pact for Lorcaserin,2012-05-10 17:31:00-04:00,ARNA,positive
94890.0,"Vivus, Orexigen Spiking Higher After-Hours Following Positive FDA Panel Vote on Arena Diet Drug",2012-05-10 16:43:00-04:00,ARNA,positive
94891.0,FDA Panel Votes 18-4-1 That Available Data Demonstrate Potential Benefits of Arena Pharmaceutical's Lorcaserin Outweigh Potential Risks ,2012-05-10 16:04:00-04:00,ARNA,positive
94892.0,FDA Panel Votes 18 Yes  4 No 1 Abstain on Arena's Lorcaserin,2012-05-10 16:03:00-04:00,ARNA,positive
94893.0,Vivus Spiking Lower Ahead of FDA Panel Vote On Arena's Lorcaserin,2012-05-10 15:53:00-04:00,ARNA,negative
94894.0,FDA Panel Currently Interviewing Patients Who Took Arena Pharmaceuticals' Lorcaserin Diet Drug; Comments are Favorable,2012-05-10 14:14:00-04:00,ARNA,positive
94895.0,"Social Media Outlook for Thursday May 10 (PRIM, LEAP, CSCO, JNPR)",2012-05-10 11:24:00-04:00,ARNA,neutral
94896.0,Arena Pharmaceuticals Halted for FDA Panel,2012-05-10 07:01:00-04:00,ARNA,neutral
94897.0,"Option Alert: Arena Pharmaceuticals July 1 Put, Block Trade, 6,800 Contracts, Currently $3.74",2012-05-09 15:09:00-04:00,ARNA,negative
94898.0,"Option Alert: Arena Pharmaceuticals July 1 Put, Block Trade, 6,800 Contracts",2012-05-09 15:09:00-04:00,ARNA,negative
94899.0,"Social Media Outlook for Wednesday May 9 (PDC, DIS, STEC, FOSL)",2012-05-09 13:06:00-04:00,ARNA,neutral
94900.0,Arena Pharmaceuticals Spiking Lower on Heavy Volume; Currently at $3.6,2012-05-09 09:36:00-04:00,ARNA,negative
94901.0,"BMO Capital Markets Upgrades Arena Pharmaceuticals from Market Perform to Outperform, Raises PT from $1 to $7",2012-05-09 07:27:00-04:00,ARNA,neutral
94902.0,"Stock Watch List for Wednesday May 9, 2012",2012-05-08 17:28:00-04:00,ARNA,neutral
94903.0,"Option Alert: Arena Pharmaceuticals July 7 Call, Block Trade, 9,124 Contracts",2012-05-08 13:46:00-04:00,ARNA,negative
94904.0,FDA Review of Arena Pharmaceuticals Obesity Drug Sunnier Than Expected -Adam F Tweet,2012-05-08 12:15:00-04:00,ARNA,positive
94905.0,"Option Alert: Arena Pharmaceuticals May 2.5 Call, Block Trade, 6,000 Contracts; Currently $3.24",2012-05-08 10:38:00-04:00,ARNA,negative
94906.0,"Social Media Outlook for Tuesday May 8 (LPX, DTV, MAKO, FOSL)",2012-05-08 10:34:00-04:00,ARNA,neutral
94907.0,Arena Pharmaceuticals Trading 22.4% Higher on Heavy Volume; Currently at $3.33,2012-05-08 09:31:00-04:00,ARNA,neutral
94908.0,Arena Pharmaceuticals Rises 18% Pre-Market ahead of FDA Advisory Committee Meeting on May 10,2012-05-08 09:26:00-04:00,ARNA,neutral
94909.0,FDA Says No Definiteive Comments Can Be Made Regarding Breast Cancer in Women in Phase 3 Trials of Arena's Larcaserin -Reuters ,2012-05-08 09:21:00-04:00,ARNA,negative
94910.0,Arena Pharmaceuticals Awaits FDA Advisory Committee Meeting ,2012-05-07 12:49:00-04:00,ARNA,positive
94911.0,Four Hot Stocks to watch Tomorrow,2012-05-02 17:46:00-04:00,ARNA,neutral
94912.0,Arena Pharmaceuticals Trading 25.8% Higher on Heavy Volume; Currently at $2.7,2012-04-27 13:33:00-04:00,ARNA,neutral
94913.0,"Option Alert: Arena Pharmaceuticals May 5 Call, Block Trade, 9,900 Contracts",2012-04-20 12:10:00-04:00,ARNA,negative
94914.0,Notable Options Activity in Arena Pharmaceuticals,2012-04-17 11:19:00-04:00,ARNA,neutral
94915.0,Setups to Watch For Thursday,2012-04-11 17:18:00-04:00,ARNA,neutral
94916.0,Martin Shkreli Says Arena is a Great Short,2012-04-11 14:11:00-04:00,ARNA,positive
94917.0,Benzinga's Top Pre-Market Gainers,2012-04-10 08:13:00-04:00,ARNA,positive
94918.0,"Arena Pharmaceuticals Releases 14A, Date of Annual Meeting June 15, Shareholders to Vote on Increasing Shares to 375M",2012-04-09 17:24:00-04:00,ARNA,positive
94919.0,"Option Alert: Arena Pharmaceuticals July 3 Call; Block Trade, 18,500 Contracts",2012-04-05 13:34:00-04:00,ARNA,negative
94920.0,"Option Alert: Arena Pharmaceuticals May 5 Call; Block Trade, 9,600 Contracts",2012-04-05 13:27:00-04:00,ARNA,negative
94921.0,Significant Bid Volume on Arena Pharmaceuticals at $3.04; 1M Shares,2012-04-03 14:53:00-04:00,ARNA,positive
94922.0,FDA Spokesperson Says Unlikely That Discussion Over Past Couple of Days Will Impact Any Existing Applications -Adam F. Tweet,2012-03-30 06:53:00-04:00,ARNA,neutral
94923.0,Arena Pharmaceuticals Trading 11.1% Higher on Heavy Volume; Currently at $3.24,2012-03-29 10:34:00-04:00,ARNA,neutral
94924.0,Arena Pharmaceuticals Falls 5% Pre-Market on Piper Downgrade,2012-03-28 07:51:00-04:00,ARNA,neutral
94925.0,UPDATE: Piper Jaffray Downgrades Arena Pharmaceuticals to Neutral,2012-03-28 06:36:00-04:00,ARNA,neutral
94926.0,"Piper Jaffray Downgrades Arena Pharmaceuticals from Overweight to Neutral, Maintains PT at $2.5",2012-03-28 06:08:00-04:00,ARNA,negative
94927.0,"Option Alert: Arena Pharmaceuticals May 2 Put; Block Trade, 4,49 Contracts",2012-03-27 12:17:00-04:00,ARNA,negative
94928.0,"Morning Social Media Outlook for Tuesday March 27 (ISTA, LNDC, CALM, MAPP)",2012-03-27 10:19:00-04:00,ARNA,positive
94929.0,Arena Pharmaceuticals Trading 13.6% Higher on Heavy Volume; Currently at $3.42,2012-03-27 10:07:00-04:00,ARNA,neutral
94930.0,Arena Pharmaceuticals up 21% on European Medicines Agency's Acceptance of Lorcaserin,2012-03-26 11:10:00-04:00,ARNA,positive
94931.0,Arena Pharmaceuticals Trading 22% Higher on Heavy Volume; Currently at $2.94,2012-03-26 11:01:00-04:00,ARNA,neutral
94932.0,Morning Market Movers,2012-03-26 09:48:00-04:00,ARNA,neutral
94933.0,Arena Pharmaceuticals Spiking Higher,2012-03-26 09:32:00-04:00,ARNA,neutral
94934.0,Arena Pharmaceuticals Rises 10% Pre-Market on European Medicines Agency's Acceptance Of Lorcaserin Marketing Authorization Application For Weight Control,2012-03-26 08:22:00-04:00,ARNA,positive
94935.0,Benzinga's Top Pre-Market Gainers,2012-03-26 08:08:00-04:00,ARNA,positive
94936.0,Arena Pharmaceuticals Announces European Medicines Agency's Acceptance of Lorcaserin Marketing Authorization Application for Weight Control ,2012-03-26 08:00:00-04:00,ARNA,positive
94937.0,Great looking setups to watch next week,2012-03-23 19:28:00-04:00,ARNA,positive
94938.0,Arena Pharmaceuticals Trading 14.2% Higher on Heavy Volume; Currently at $2.33,2012-03-23 14:58:00-04:00,ARNA,neutral
94939.0,Healthcare Investors And Capitalists Actively Looking For The Next Generation Of Market Movers -Reuters,2012-03-23 14:15:00-04:00,ARNA,positive
94940.0,"Option Alert: Arena Pharmaceuticals May 3.5 Call; Block Trade, 2,689 Contracts",2012-03-21 15:52:00-04:00,ARNA,negative
94941.0,Top Stocks to watch for Wednesday,2012-03-20 18:02:00-04:00,ARNA,positive
94942.0,Arena Pharma Reports Q4 EPS $(0.16) vs $(0.15) Est; Revenues $2.08M vs $3.49M Est,2012-03-14 16:09:00-04:00,ARNA,neutral
94943.0,"Arena Pharmaceuticals Offering  14,414,370 Shares Of Common Stock",2012-03-08 16:27:00-05:00,ARNA,positive
94944.0,"Arena Pharma Files for EMA Application, Hopes to Cure Weight Loss",2012-03-02 13:37:00-05:00,ARNA,positive
94945.0,Hearing Piper Jaffray Positive on Arena Pharmaceuticals,2012-03-02 12:23:00-05:00,ARNA,positive
94946.0,Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control,2012-03-02 08:01:00-05:00,ARNA,neutral
94947.0,"U.S. Obesity Spells Opportunity for VVUS, OREX and ARNA",2012-02-23 14:25:00-05:00,ARNA,positive
94948.0,Vivus Investors Rejoice as Weight Loss Drug Receives Positive Panel Vote,2012-02-23 13:26:00-05:00,ARNA,positive
94949.0,Benzinga's Top Pre-Market Gainers,2012-02-23 08:34:00-05:00,ARNA,positive
94950.0,Arena Pharmaceuticals Rises 19% on Positive FDA Panel Vote on Vivus' Qnexa,2012-02-22 17:52:00-05:00,ARNA,positive
94951.0,Arena Pharmaceuticals Rises 10% on Positive FDA Panel Vote on Vivus' Qnexa,2012-02-22 17:11:00-05:00,ARNA,positive
94952.0,Orexigen Therapeutics and Arena Pharmaceuticals Soar On Positive Qnexa Panel Vote,2012-02-22 17:07:00-05:00,ARNA,positive
94953.0,"Orexigen Therapeutics, Arena Pharmaceuticals Spike Higher as FDA Panels Prepares to Vote on Vivus' Qnexa",2012-02-22 15:39:00-05:00,ARNA,neutral
94954.0,Vivus Hoping Weight Loss Drug Will Gain Approval as FDA Releases Briefing Documents,2012-02-17 09:39:00-05:00,ARNA,positive
94955.0,"Option Alert: Arena Pharmaceuticals July 3 Call; Block Trade, 3,920 Contracts",2012-02-06 10:24:00-05:00,ARNA,negative
94957.0,Arena Pharmaceuticals Announces $33 Million Financing ,2012-01-11 06:54:00-05:00,ARNA,neutral
94958.0,Will This Drug Help You Lose Weight Without Exercise?,2012-01-10 13:09:00-05:00,ARNA,neutral
94959.0,Piper Jaffray Maintains Overweight on Arena Pharma After FDA Approval This Morning,2012-01-10 12:27:00-05:00,ARNA,positive
94960.0,Arena Pharmaceuticals Announces FDA Accepts Resubmission of Lorcaserin New Drug Application ,2012-01-10 08:03:00-05:00,ARNA,positive
94961.0,Jefferies Provides Update on Arena Pharmaceuticals,2012-01-04 09:50:00-05:00,ARNA,neutral
94962.0,"End-of-Day Market Summary for January 3, 2012",2012-01-03 16:17:00-05:00,ARNA,neutral
94963.0,Arena Submits Response to FDA Complete Response Letter for Lorcaserin ,2012-01-03 16:02:00-05:00,ARNA,neutral
94964.0,Benzinga's Top Pre-Market Gainers,2011-12-13 08:23:00-05:00,ARNA,positive
94965.0,Arena Pharmaceuticals Spiking Higher on Heavy Volume,2011-12-09 12:21:00-05:00,ARNA,neutral
94966.0,Arena Pharmaceuticals Hits 52-Week High of $2.08,2011-12-09 12:04:00-05:00,ARNA,neutral
94967.0,Biotech Stocks On the Move,2011-12-05 17:26:00-05:00,ARNA,neutral
94968.0,"Piper Jaffray Reiterates Overweight, $3 Target on Arena Pharmaceuticals ",2011-11-30 10:08:00-05:00,ARNA,negative
94969.0,Is Arena Pharma Going to Cure Obesity?,2011-11-28 16:57:00-05:00,ARNA,neutral
94970.0,UPDATE: Piper Jaffray Upgrades Arena Pharma to Overweight and Raises PT to $3 ,2011-11-28 07:39:00-05:00,ARNA,negative
94971.0,"Piper Jaffray Upgrades Arena Pharmaceuticals to Overweight, PT Raised to $3",2011-11-28 05:53:00-05:00,ARNA,negative
94972.0,Oppenheimer Maintains Perform Rating on Arena Pharmaceuticals ,2011-11-11 10:14:00-05:00,ARNA,neutral
94973.0,Arena Reports EPS $(0.16) vs $(0.14) Est; Revenue $3.46M vs $3.37M Est,2011-11-09 17:06:00-05:00,ARNA,neutral
94974.0,Hearing Chatter Piper Jaffray Making Positive Comments on Arena Pharma,2011-09-21 11:26:00-04:00,ARNA,positive
94975.0,UPDATE: Vivus and Arena Pharmaceuticals Spike Higher on Orexigen Therapeutics News,2011-09-20 16:04:00-04:00,ARNA,neutral
94976.0,"Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer ",2011-08-12 08:00:00-04:00,ARNA,neutral
94977.0,Bank of America Looks Ahead on Arena Pharmaceuticals,2011-08-10 07:21:00-04:00,ARNA,neutral
94978.0,Oppenheimer Reviews Arena Pharmaceuticals at the Quarter,2011-08-10 06:50:00-04:00,ARNA,neutral
94979.0,Arena Pharmaceuticals Reports Q2 EPS $(0.16) vs $(0.16) Est; Revenues $3.26M vs $3.35M Est		,2011-08-09 16:07:00-04:00,ARNA,neutral
94980.0,Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study,2011-08-09 07:03:00-04:00,ARNA,neutral
94981.0,Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses  ,2011-08-02 07:25:00-04:00,ARNA,neutral
94982.0,Biotech Stocks to Watch for Thursday,2011-07-27 17:31:00-04:00,ARNA,neutral
94983.0,5 Stocks for Your Watchlist,2011-07-25 18:06:00-04:00,ARNA,neutral
94984.0,Arena Pharmaceuticals Breaks Higher; Now Up 6+%,2011-07-25 14:45:00-04:00,ARNA,neutral
94985.0,Arena Pharmaceuticals Trades to Two Month High,2011-07-22 15:10:00-04:00,ARNA,neutral
94986.0,Options Brief: Arena Pharmaceuticals,2011-07-19 15:37:00-04:00,ARNA,neutral
94987.0,Arena Says APD811 Showed Proportionate Pharmacokinetic Exposure,2011-07-12 08:11:00-04:00,ARNA,neutral
94988.0,Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension,2011-07-12 08:01:00-04:00,ARNA,neutral
94989.0,Options Brief: Arena Pharmaceuticals,2011-07-11 13:17:00-04:00,ARNA,neutral
94990.0,Momentum Stocks For Next Week,2011-07-02 17:26:00-04:00,ARNA,neutral
94991.0,"Stock Picks and Trade Ideas for Friday, June 10",2011-06-09 17:04:00-04:00,ARNA,neutral
94992.0,Some stock trading ideas for June 3rd,2011-06-02 16:31:00-04:00,ARNA,neutral
94993.0,"Hapoalim Securities Terminates Healthcare Coverage Including Bristol-Myers, Eli Lilly, Merck and Pfizer",2011-06-01 12:13:00-04:00,ARNA,positive
94994.0,Hapoalim Cutting Ocverage On Multitude Of Names,2011-06-01 11:48:00-04:00,ARNA,negative
94995.0,"Options Brief: Arena Pharmaceuticals, Inc.",2011-05-26 10:21:00-04:00,ARNA,neutral
94996.0,Morning Market Movers,2011-05-26 09:55:00-04:00,ARNA,neutral
94997.0,Arena Pharma Ticking Over 15% Higher after Positive Phase 3 Trial Data,2011-05-26 09:49:00-04:00,ARNA,positive
94998.0,Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals' Lorcaserin Achieved Statistically Significant Weight Loss,2011-05-26 08:13:00-04:00,ARNA,negative
94999.0,Should Hartford Financial sell Federal Trust Corp. to CenterState Banks Inc.?,2011-05-23 14:36:00-04:00,ARNA,positive
95000.0,"Top Forestry, Wood and Non-Metallic Mining Stocks to watch on 5/23/11- POPE, WY, TREX, DEL, UFPI, HWD, SHZ, MDM, CMP",2011-05-23 04:22:00-04:00,ARNA,positive
95001.0,Stock Watchlist For Next Week,2011-05-20 18:26:00-04:00,ARNA,neutral
95002.0,Arena Pharma Rallies in Sympathy with Vivus Phase 3 Results,2011-05-17 12:31:00-04:00,ARNA,positive
95003.0,Oppenheimer Raises EPS Estimate From $0.58 To $0.69 On ARNA,2011-05-11 07:27:00-04:00,ARNA,neutral
95004.0,Arena Pharma Will Submit CRL Response by Late 2011 (ARNA),2011-05-10 16:10:00-04:00,ARNA,neutral
95005.0,Arena Pharma Reports Q1 EPS of $(0.35) vs. $(0.21) Estimate; Revenues $3.9M vs. $3.29M Estimate (ARNA),2011-05-10 16:09:00-04:00,ARNA,neutral
95006.0,"Daytrading Stocks to Watch for 04/28- SSN, HDY, DRYS, ARNA, IRE, CYCC, SOMX, REDF, AIB, YRCW, SHZ, LLNW, LVLT, JSDA",2011-04-28 06:07:00-04:00,ARNA,neutral
95007.0,Options Brief: Arena Pharmaceuticals (ARNA),2011-04-26 11:32:00-04:00,ARNA,neutral
95008.0,"CEOWORLD Stocks Picks to Watch on 4/26/11 – NFLX, BIDU, ORCL, YRCW, KOG, SSN, AMZN, PZG, AIG, AMD, GS, POT…",2011-04-26 10:05:00-04:00,ARNA,neutral
95009.0,Top Trade Ideas for Wednesday April 06,2011-04-05 18:12:00-04:00,ARNA,positive
95010.0,Arena Pharmaceuticals Announces $35.5M Financing  ,2011-03-29 06:46:00-04:00,ARNA,neutral
95011.0,A Peek Into The Market Before The Trading Starts,2011-03-11 07:31:00-05:00,ARNA,neutral
95012.0,Arena Pharmaceuticals Reports Q4 EPS of $(0.23) vs. $(0.21),2011-03-11 07:07:00-05:00,ARNA,neutral
95013.0,US Stock Futures Down After Japan Earthquake Triggers Off Tsunami Warnings,2011-03-11 06:26:00-05:00,ARNA,negative
95014.0,"Earnings Scheduled For March 11 (AWR, HIBB, BIOS, ANN, ARNA, LMIA, HALO, UTSI, PKT, NGPC, SNTA)",2011-03-11 03:12:00-05:00,ARNA,neutral
95015.0,"How To Trade The FDA Modernization (BIIB, IBB, ARNA, VVUS, AMGN)",2011-02-25 13:20:00-05:00,ARNA,neutral
95016.0,"Top Trade Ideas for Friday, February 25",2011-02-24 16:58:00-05:00,ARNA,positive
95017.0,Arena Pharmaceuticals Announces Upcoming Departure of CFO,2011-02-10 17:02:00-05:00,ARNA,neutral
95018.0,"Stock Market Ideas for Thursday, February 10",2011-02-09 17:30:00-05:00,ARNA,neutral
95019.0,Setback for Orexigen - Analyst Blog,2011-02-02 09:52:00-05:00,ARNA,neutral
95020.0,Setback for Orexigen - Analyst Blog,2011-02-02 09:30:00-05:00,ARNA,neutral
95021.0,What's Hot on TheStreet,2011-02-01 12:35:00-05:00,ARNA,neutral
95022.0,"Trading Orexigen Therapeutics Terrible Results (OREX, ARNA, VVUS)",2011-02-01 08:26:00-05:00,ARNA,negative
95023.0,"Stock Market Ideas for Monday, January 31",2011-01-30 06:31:00-05:00,ARNA,neutral
95024.0,Arena Pharmaceuticals to Reduce US Workforce by 25%,2011-01-27 16:24:00-05:00,ARNA,neutral
95025.0,Arena Pharmaceuticals Announces Workforce Reduction and Provides Lorcaserin Regulatory Update,2011-01-27 16:22:00-05:00,ARNA,neutral
95026.0,"3 Stocks For New Year's Diets (ARNA, VVUS, OREX) ",2010-12-30 11:25:00-05:00,ARNA,neutral
95027.0,Arena Pharmaceuticals Up On Diet Drug Update (ARNA),2010-12-27 10:35:00-05:00,ARNA,neutral
95028.0,Vivus Seeks EU Nod for Qnexa - Analyst Blog,2010-12-27 09:30:00-05:00,ARNA,neutral
95029.0,Vivus Seeks EU Nod for Qnexa - Analyst Blog,2010-12-27 08:45:00-05:00,ARNA,neutral
95030.0,Hapoaliom Views Arena's Lorcaserin As Unapprovable,2010-12-23 09:12:00-05:00,ARNA,neutral
95031.0,"Arena: Long, Hard 'Path' to Obesity Drug Approval",2010-12-22 13:05:00-05:00,ARNA,positive
95032.0,ARNA Intraday Update: Shareholders Exiting (ARNA),2010-12-22 10:49:00-05:00,ARNA,neutral
95033.0,"Benzinga's Top Pre-Market NASDAQ Gainers (ATVI, ARNA, NVMI, ARMH)",2010-12-22 08:23:00-05:00,ARNA,positive
95034.0,Arena Pharmaceuticals Down 3% After Resumed Trading,2010-12-22 08:19:00-05:00,ARNA,neutral
95035.0,Arena Pharmaceuticals Set To Reopen 8:15am After FDA End-Of-Review (ARNA),2010-12-22 08:13:00-05:00,ARNA,neutral
95036.0,Arena and Eisai Complete Meeting with FDA,2010-12-22 07:34:00-05:00,ARNA,neutral
95037.0,Arena Pharmaceuticals Has A Conference Call Tomorrow Morning To Discuss FDA Meeting,2010-12-21 18:25:00-05:00,ARNA,neutral
95038.0,"Benzinga's Top Pre-Market NASDAQ Losers (ARNA, ARTG, VOD, INTC)",2010-12-21 08:18:00-05:00,ARNA,negative
95039.0,Calls Purchased on Arena Pharmaceuticals (ARNA),2010-12-20 14:01:00-05:00,ARNA,neutral
95040.0,VIVUS Up Pre-Market ,2010-12-13 08:38:00-05:00,ARNA,neutral
95041.0,Orexigen Therapeutics Dropping After Monster Gain Yesterday,2010-12-09 10:02:00-05:00,ARNA,positive
95042.0,Worst Biotech CEO of 2010 Is...,2010-12-09 07:01:00-05:00,ARNA,negative
95043.0,FDA Panel Backs OREX's Contrave  - Analyst Blog,2010-12-08 16:03:00-05:00,ARNA,negative
95044.0,FDA Panel Backs OREX's Contrave  - Analyst Blog,2010-12-08 15:42:00-05:00,ARNA,negative
95045.0,Options Brief: Arena Pharmaceuticals (ARNA),2010-12-08 13:24:00-05:00,ARNA,neutral
95046.0,Biotechnology Stocks Hot Off Of Orexigen Panel Vote,2010-12-08 13:01:00-05:00,ARNA,neutral
95047.0,Orexigen Therapeutics Off Highs (OREX),2010-12-08 12:47:00-05:00,ARNA,neutral
95048.0,"Morning Market Movers (OREX, FCEC, VVUS, ARNA)",2010-12-08 10:03:00-05:00,ARNA,neutral
95049.0,FDA Panel Approves Orexigen Diet Drug Contrave,2010-12-07 17:28:00-05:00,ARNA,positive
95050.0,Orexigen Therapeutics: FDA Panel Live Blog,2010-12-07 07:47:00-05:00,ARNA,neutral
95051.0,Orexigen: Predicting Tuesday's FDA Panel,2010-12-03 10:35:00-05:00,ARNA,neutral
95052.0,Biotech Stock Mailbag: Amarin,2010-12-03 07:00:00-05:00,ARNA,neutral
95053.0,Vote for the Worst Biotech CEO of 2010,2010-12-01 07:00:00-05:00,ARNA,negative
95054.0,Orexigen: Contrave FDA Panel Preview,2010-11-30 07:57:00-05:00,ARNA,neutral
95055.0,Bramson Plutzik and Sherman Business Law File Class Action Suit Against Arena Pharmaceuticals,2010-11-16 15:18:00-05:00,ARNA,neutral
95056.0,Soros Adds To Apple Position (AAPL),2010-11-15 17:29:00-05:00,ARNA,neutral
95057.0,Arena Waiting On FDA Approval Of Lorcaserin,2010-11-10 08:09:00-05:00,ARNA,positive
95058.0,Hapoalim Reiterates Sell Rating on Arena Pharmaceuticals (ARNA),2010-11-09 11:44:00-05:00,ARNA,neutral
95059.0,A Peek Into The Market Before The Trading Starts,2010-11-09 07:23:00-05:00,ARNA,neutral
95060.0,Arena Pharmaceuticals Posts Mixed Results (ARNA),2010-11-09 06:42:00-05:00,ARNA,neutral
95061.0,Arena Pharmaceuticals Reports Wider-Than-Expected Q3 Loss,2010-11-09 06:19:00-05:00,ARNA,negative
95062.0,Biotech Stock Mailbag: Orexigen ,2010-11-05 11:12:00-04:00,ARNA,neutral
95063.0,Rude Shock for Arena Pharma - Analyst Blog,2010-10-25 14:33:00-04:00,ARNA,negative
95064.0,Hapoalim Securities Doesn't See Strong Future For Arena Pharmaceuticals (ARNA),2010-10-25 11:10:00-04:00,ARNA,negative
95065.0,FDA Issues Complete Response For Arena's Lorcaserin,2010-10-25 10:08:00-04:00,ARNA,neutral
95066.0,Arena Pharmaceuticals Announces Phase 1 Results for APD916 ,2010-10-20 08:08:00-04:00,ARNA,neutral
95067.0,Don't Fall In to the Leverage Trap!,2010-10-15 08:35:00-04:00,ARNA,negative
95068.0,Arena Pharmaceuticals Skyrocketing (ARNA),2010-10-04 14:20:00-04:00,ARNA,neutral
95069.0,Readers Pick Drug Approval Winners & Losers,2010-10-04 07:15:00-04:00,ARNA,positive
95070.0,"Zings Of The Day (ARNA, GS, ORCL, RIMM)",2010-09-17 16:04:00-04:00,ARNA,neutral
95071.0,"Mid-Day Options Volume Leaders (RIMM, C, AAPL, ORCL, ARNA)",2010-09-17 12:43:00-04:00,ARNA,neutral
95072.0,Arena Pharma Craters on FDA Rejection (ARNA),2010-09-17 09:41:00-04:00,ARNA,negative
95073.0,Arena Downgraded To Neutral,2010-09-17 09:25:00-04:00,ARNA,neutral
95074.0,"Benzinga's Top Pre-Market NASDAQ Losers (ARNA, OREX, ACFN, VVUS)",2010-09-17 09:21:00-04:00,ARNA,negative
95075.0,Hapoalim Securities Reiterates Sell On Arena Pharmaceuticals (ARNA),2010-09-17 08:35:00-04:00,ARNA,positive
95076.0,"Benzinga's Top Downgrades (IGT, MEE, ARNA, NBL)",2010-09-17 08:02:00-04:00,ARNA,positive
95077.0,Piper Jaffray Downgrades ARNA To Neutral,2010-09-17 07:17:00-04:00,ARNA,neutral
95078.0,Arena Pharmaceuticals Falls 40% On FDA Rejection (ARNA),2010-09-16 17:31:00-04:00,ARNA,negative
95079.0,Arena and Eisai Provide Update on Lorcaserin FDA Meeting,2010-09-16 16:43:00-04:00,ARNA,neutral
95080.0,Strong Response To Live Blog On Arena (ARNA),2010-09-16 15:34:00-04:00,ARNA,positive
95081.0,"Wednesday's Mid-Day Options Volume Leaders (YHOO, ARNA, AAPL, BAC, C)",2010-09-15 11:20:00-04:00,ARNA,neutral
95082.0,"Benzinga's Top Pre-Market NASDAQ Losers (ARNA, ATML, RDWR, LOGI)",2010-09-15 09:24:00-04:00,ARNA,negative
95083.0,Hapoalim Securities Lowering Price Target On Arena Pharmaceuticals (ARNA),2010-09-15 08:28:00-04:00,ARNA,positive
95084.0,"Tuesday's Mid-Day Options Volume Leaders (BAC, ARNA, C, MSFT, YHOO)",2010-09-14 12:33:00-04:00,ARNA,neutral
95085.0,Correction: Arena Hit Hard After Initial FDA Findings (ARNA),2010-09-14 10:18:00-04:00,ARNA,negative
95086.0,Arena Pharma Down 40% on FDA Leak (ARNA) ,2010-09-14 09:50:00-04:00,ARNA,negative
95087.0,"Benzinga's Top Pre-Market NASDAQ Losers (ARMH, NUVA, ARNA, THQI)",2010-09-14 09:26:00-04:00,ARNA,negative
95088.0,Arena Pharmaceuticals Getting Hit Hard After FDA Ruling (ARNA),2010-09-14 09:22:00-04:00,ARNA,negative
95089.0,Barclays Downgrades ARNA To Underperform ,2010-09-14 07:19:00-04:00,ARNA,neutral
95090.0,"Cramer Sets Rules For New Bullish Market (BA, HON, LVS, WYNN, BUCY, JOYG, APD, ARG, CAT, DE, WHR, INTC, KO, PEP, ETP, WMT, FE, SYK, UA, LULU, DKS, LTD, PBCT, CHK, ARNA, CLNE)",2010-09-14 06:50:00-04:00,ARNA,neutral
95091.0,"Jim Cramer's Mad Money Lightning Round Recap (ARNA, FE, SYK, UA, LTD, PBCT, CHK, CLNE)",2010-09-13 20:47:00-04:00,ARNA,negative
95092.0,Vol Extremely Elevated in Arena Pharma (ARNA),2010-09-13 11:35:00-04:00,ARNA,neutral
95093.0,"Benzinga's Top Pre-Market NASDAQ Losers (SGEN, ARNA, HGSI, GOLD)",2010-09-13 09:21:00-04:00,ARNA,negative
95094.0,Hapoalim Securities Downgrading Arena Pharmaceuticals To Sell (ARNA),2010-09-09 08:28:00-04:00,ARNA,positive
95095.0,Lorcaserin Meeting On 9/16,2010-09-07 11:59:00-04:00,ARNA,neutral
95096.0,"Benzinga’s Top Pre-Market NASDAQ Gainers (MNTA, SOLF, NFLX, ARNA)",2010-08-26 08:41:00-04:00,ARNA,positive
95097.0,Mad Money Lightning – Cramer’s Take On Stocks,2010-08-25 07:03:00-04:00,ARNA,negative
95098.0,"Mad Money Lightning Round OT (TKR, ARNA, OSK)",2010-08-24 19:39:00-04:00,ARNA,negative
95099.0,"2H:10 Milestones In Drug Discovery (ARNA, VRTX, REGN, EXEL)",2010-08-18 11:28:00-04:00,ARNA,neutral
95100.0,US Patent Office Grants Arena Pharmaceuticals Patent For Alzheimers Disease (ARNA),2010-08-17 14:16:00-04:00,ARNA,positive
95101.0,Arena Pharmaceuticals To Release Briefing Documents On September 14 Over Lorcaserin,2010-08-13 10:18:00-04:00,ARNA,neutral
95102.0,"Benzinga’s Top Pre-Market NASDAQ Losers (PSTB, TSTC, PDLI, ARNA)",2010-08-13 09:22:00-04:00,ARNA,negative
95103.0,Jefferies Upping Target On Arena Pharmaceuticals (ARNA),2010-08-04 10:28:00-04:00,ARNA,neutral
95104.0,A Peek Into The Market Before The Trading Starts,2010-08-04 09:03:00-04:00,ARNA,neutral
95105.0,Hapoalim Securities Lowers Arena Pharmaceuticals To Hold (ARNA),2010-08-04 08:54:00-04:00,ARNA,positive
95106.0,Reason Yen's Move is Not Bullish for Japan 08-03-2010,2010-08-03 18:40:00-04:00,ARNA,neutral
95107.0,Arena Pharmaceuticals Reports Results,2010-08-03 16:29:00-04:00,ARNA,neutral
95108.0,Steve Grasso's Arena Pharmaceuticals (ARNA) Trade,2010-08-02 19:31:00-04:00,ARNA,neutral
95109.0,"Benzinga’s Top Pre-Market NASDAQ Losers (ARNA, GOLD, ITRN, RIMM)",2010-08-02 09:25:00-04:00,ARNA,negative
95110.0,"Jim Cramer's Mad Money Lightning Round (WYNN, ARNA, PTV, TIN, CY, RMBS, NVDA, ORCL, APKT)   ",2010-07-31 08:54:00-04:00,ARNA,negative
95111.0,Tech Under Pressure 07-30-2010,2010-07-30 14:56:00-04:00,ARNA,negative
95112.0,"Mad Money Lightning Round OT: Cramer Wants To Stay Away From CFN (ARNA, XRTX, IBM, CFN)",2010-07-19 19:45:00-04:00,ARNA,negative
95113.0,"Benzinga’s Top Pre-Market NASDAQ Gainers (CYPB, ZAGG, ARNA, YHOO)",2010-07-19 09:03:00-04:00,ARNA,positive
95114.0,"Mid-Day Market Movers (LSBX, AVII, ARNA, TRBN)",2010-07-16 13:27:00-04:00,ARNA,neutral
95115.0,"Vivus Tumbles 70% on FDA Disapproval; Piper Jaffray Urges You to Buy Arena (ARNA, VVUS)",2010-07-16 10:07:00-04:00,ARNA,neutral
95116.0,"Benzinga’s Top Pre-Market NASDAQ Gainers (AVII, ARNA, AIXG, ATPG)  ",2010-07-16 08:32:00-04:00,ARNA,positive
95117.0,"Benzinga's After Hours Gainers (GS, ARNA, SD)",2010-07-15 18:38:00-04:00,ARNA,neutral
95118.0,Deflation Potentially More of a Threat  07-15-2010,2010-07-15 15:01:00-04:00,ARNA,negative
95119.0,"Top Performing Industries For July 15 (NTY, CF, ARNA, MYL)",2010-07-15 14:51:00-04:00,ARNA,positive
95120.0,Jeffries & Co. Maintain Their HOLD Rating on ARNA,2010-07-15 10:01:00-04:00,ARNA,neutral
95121.0,Piper Jaffray Reiterates Overweight on Arena Pharmaceuticals (ARNA),2010-07-15 09:25:00-04:00,ARNA,negative
95122.0,"Benzinga’s Top Pre-Market NASDAQ Gainers (ARNA, SHPGY, CSIQ, GOLD)",2010-07-15 09:03:00-04:00,ARNA,positive
95123.0,Unemployment Impacting Retail Sales  07-14-2010,2010-07-14 15:03:00-04:00,ARNA,negative
95124.0,"Benzinga’s Top Pre-Market Gainers (VVUS, OREX, ARNA, CENX)",2010-07-13 08:33:00-04:00,ARNA,positive
95125.0,Oversold Bounce in Bearish Market  07-06-2010,2010-07-06 14:55:00-04:00,ARNA,neutral
95126.0,Puts Purchased on Arena Pharmaceuticals (ARNA),2010-07-06 10:33:00-04:00,ARNA,neutral
95127.0,"Benzinga’s Top Pre-Market Gainers (ARNA, LOGI, TSLA, CRUS)",2010-07-02 08:56:00-04:00,ARNA,positive
95128.0,"Benzinga’s Top Upgrades (BJ, NI, ARNA, AEG)",2010-07-02 07:31:00-04:00,ARNA,positive
95129.0,"Piper Jaffray Says Arena Pharmaceuticals Going To $10, Shares Fly Higher (ARNA) ",2010-07-01 12:35:00-04:00,ARNA,positive
95130.0,ARNA Soars On Partnership Deal With Eisai,2010-07-01 09:41:00-04:00,ARNA,neutral
95131.0,"Benzinga’s Top Pre-Market Gainers (ARNA, ISLE, SWHC, SWKS)",2010-07-01 08:42:00-04:00,ARNA,positive
95132.0,"Early Volume Plays Among Those Valued Below $10 (BIOD, ARNA, OREX)",2010-06-28 14:34:00-04:00,ARNA,positive
95133.0,"Arena And Vivus Receive ‘Hold’ Rating from Jefferies (ARNA, VVUS)",2010-06-28 11:52:00-04:00,ARNA,neutral
95134.0,Good News About Arena Pharmaceuticals (ARNA) Weight Loss Drugs,2010-06-28 10:00:00-04:00,ARNA,positive
95135.0,"Benzinga’s Top Pre-Market Gainers (ARNA, SOLF, JASO, MU)",2010-06-28 08:49:00-04:00,ARNA,positive
95136.0,"Biodel, Arena Pharma: Volume Movers",2010-06-28 08:41:00-04:00,ARNA,neutral
95137.0,FDA Considering The Approval Of ARNA’s Lorcaserin,2010-06-03 10:07:00-04:00,ARNA,positive
95138.0,"Benzinga’s Top Pre-Market Gainers (ARNA, DELL, TEVA, GOOG, APWR)",2010-05-24 08:38:00-04:00,ARNA,positive
95139.0,"Benzinga’s Top Pre-Market Gainers (HAUP, ACAS, YHOO, BPOP, ARNA)",2010-05-14 08:48:00-04:00,ARNA,positive
95140.0,Arena Pharmaceuticals (ARNA) Narrows Loss,2010-05-07 09:14:00-04:00,ARNA,negative
95141.0,"Mike Huckman Is Watching VVUS, ARNA, OREX",2010-04-12 19:32:00-04:00,ARNA,neutral
95142.0,Puts Bought in Arena,2010-03-29 09:51:00-04:00,ARNA,neutral
95143.0,Puts Purchased in Arena,2010-03-26 10:38:00-04:00,ARNA,neutral
95144.0,How Will Obama-Care Play Into The Markets And ETFs?,2010-03-21 21:50:00-04:00,ARNA,positive
95145.0,"Benzinga’s News Roundup (HALO, LACO, ANN, ARNA)",2010-03-12 08:16:00-05:00,ARNA,neutral
95146.0,"Benzinga’s Top Pre-Market Gainers (ZLC, ADSK, GLDD, SLXP, ARNA)",2010-02-24 08:33:00-05:00,ARNA,positive
95147.0,Weight Loss Drug To Boost Arena Pharma’s Future (ARNA),2009-12-28 13:24:00-05:00,ARNA,positive
95148.0,Merck Decides To Discontinue Its Collaboration With ARNA For Dyslipidemia,2009-12-24 10:35:00-05:00,ARNA,neutral
95149.0,"Benzinga’s Top Pre- Market Losers (AMFI, TRMS, ARNA)",2009-12-24 08:42:00-05:00,ARNA,negative
95150.0,"Benzinga’s Top Pre- Market Gainers (ACAS, GRMN, TNDM, ARNA)",2009-11-04 09:03:00-05:00,ARNA,positive
95151.0,"Stocks to Watch (ARNA,SIRI,PALM,NMM,IHS)",2009-09-18 08:39:00-04:00,ARNA,neutral
95152.0,Hapoalim Initiates Arena Pharma  (ARNA) with a Buy,2009-09-14 10:27:00-04:00,ARNA,neutral
